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ABSTRACT 
 
 
 
142Pr Glass Seeds for the Brachytherapy of Prostate Cancer. 
(May 2007) 
Jae Won Jung, B.S.; M.S., Hanyang University, Korea 
Chair of Advisory Committee: Dr. Warren D. Reece 
 
 
 
A beta-emitting glass seed was proposed for the brachytherapy treatment of 
prostate cancer. Criteria for seed design were derived and several beta-emitting nuclides 
were examined for suitability. 142Pr was selected as the isotope of choice. Seeds 0.08 cm 
in diameter and 0.9 cm long were manufactured for testing. The seeds were activated in 
the Texas A&M University research reactor. The activity produced was as expected 
when considering the meta-stable state and epi-thermal neutron flux. The MCNP5 
Monte Carlo code was used to calculate the quantitative dosimetric parameters suggested 
in the American Association of Physicists in Medicine (AAPM) TG-43/60.  
The Monte Carlo calculation results were compared with those from a dose 
point kernel code. The dose profiles agree well with each other. The gamma dose of 
142Pr was evaluated. The gamma dose is 0.3 Gy at 1.0 cm with initial activity of 5.95 
mCi and is insignificant to other organs. Measurements were performed to assess the 2-
dimensional axial dose distributions using Gafchromic radiochromic film. The 
radiochromic film was calibrated using an X-ray machine calibrated against a National 
Institute of Standards and Technology (NIST) traceable ion chamber. A calibration 
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curve was derived using a least squares fit of a second order polynomial. The measured 
dose distribution agrees well with results from the Monte Carlo simulation. The dose 
was 130.8 Gy at 6 mm from the seed center with initial activity of 5.95 mCi. AAPM TG-
43/60 parameters were determined. The reference dose rate for 2 mm and 6 mm were 
0.67 and 0.02 cGy/s/mCi, respectively. The geometry function, radial dose function and 
anisotropy function were generated.  
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CHAPTER I 
INTRODUCTION 
 
I-1 Background 
Over the last few decades, worldwide interest in the treatment of prostate cancer 
continually increased. A remarkable number of prostate cancers threatening men’s lives 
have been reported in many countries including the United States. Prostate cancer is the 
most common cancer, shown in Figure I-1 (American Cancer Society 2006), after skin 
cancer, and the second leading cause of cancer-related death in men in the United States. 
Between 1988 and 1992, prostate cancer incidence rates increased dramatically due to 
earlier diagnosis with prostate-specific antigen (PSA) blood testing approved by Food 
and Drug Administration (FDA) in 1986 after already increasing steadily from 1975 to 
1988. In contrast incidence rates for both lung and colorectal cancers in men have 
declined in recent years. Figure I-2 shows the prostate cancer incidence rates for men 
correlated with race in the United States (National Cancer Institute 2005). The incidence 
rate in African-Americans is the highest. Those of Asian and American Indians are the 
lowest. But considering the small population fractions of Asian and American Indians in 
the United States, the incidence risk for them is not small.  
______________________ 
The dissertation style and format follow that of Physics in Medicine and Biology. 
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Figure I-1. Cancer incidence rates for men in the United States 
 
 
 
 
Source: Surveillance, Epidemiology, and End Results Program 
and the National Center for Health Statistics. 
Figure I-2. Prostate cancer incidence rates for men in the U.S. with race 
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PSA blood testing enables doctors to find prostate cancer earlier and more easily. 
Early stage prostate cancer should be treated effectively with recurrence-free survival as 
the goal. Even though it is a slow growing cancer, optimized treatments should be 
selected considering quality of life after treatment. Several options for the treatment of 
prostate cancer exist, such as radical prostatectomy, watchful waiting, or radiation 
treatment (external beam radiation therapy or prostate brachytherapy). Surgical removal 
of the prostate can cause side effects such as erectile dysfunction or urinary incontinence. 
Intensity modulated radiation therapy or 3D conformal therapy can give at most 85~90 
Gy to a prostate tumor, while brachytherapy can deliver about 150 Gy to a tumor. 
Considering the small α/β ratio reported in the literature (King and Fowler 2001), higher 
doses to the tumor are preferred.  
The most promising treatment option is prostate brachytherapy, also known as a 
radioactive seed implant. Prostate brachytherapy can be used effectively for early stage 
prostate cancers before metastasis. A cross-sectional survey conducted by Wei et al. 
(2002) shows, in Figure I-3, that even though the brachytherapy is known for low 
morbidity and high recurrence-free survival, the current method of the brachytherapy 
treatment of prostate cancer is not preferred in terms of quality of life issues. As reported 
by Wallner et al. (1995), the dose to the urethra and rectal wall from conventional 
brachytherapy could be more than 360 Gy and 90 Gy respectively. This undesirable dose 
to adjacent organs is not insignificant and can cause not only deterministic effects but 
also the probabilistic effects such as a radiation-induced second cancer. Brenner et al. 
(2000) reported a pattern of radiation-induced second cancer after the radiotherapy of 
4 
 
 
prostate cancer. Brenner et al. reported that 10-year survival patients of prostate cancer 
after radiotherapy showed 34% risk increase of a radiation-induced second cancer. 
About 50 % of the radiation-induced second cancers were bladder and rectal cancer. For 
these reasons, the undesirable dose to other organs should be minimized during 
radiotherapy.   
 
 
 
Figure I-3. Cross-sectional survey for health-related quality-of-life (Wei et al. 2002) 
 
I-2 Previous work 
I-2-1 Beta sources for intravascular brachytherapy 
Beta sources such as 90Y or 32P have been used primarily for vascular 
brachytherapy. A dose rate table was presented for a 27 mm long, Guidant 32P, 
intravascular brachytherapy source using Monte Carlo calculation (Bohm et al. 2001).  
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Measurements were reported for the 90Sr/90Y beta-emitter source trains used in the 
Novoste Beta-Cath system to determine the dosimetric characteristics of the sources at 
millimeter distances and to provide the necessary TG-60 dosimetry parameters for 
mapping the dose distributions (Roa et al. 2002).   
 
I-2-2 REAS glass  
Rare earth aluminosilicate (REAS) glasses have been used as radioactive 
material vehicles because they can contain 25 to 70 weight percent of beta emitting rare 
earth isotopes, e.g. 90Y, 166Ho, 153Sm, 165Dy, or 142Pr (White and Day 1994). REAS 
glasses are chemically durable and biologically inert in vivo. REAS glasses exhibit no 
measurable weight loss (>0.1mg) for up to 6 weeks in distilled water. REAS glasses can 
be easily prepared as seeds for in vivo use or as microspheres of controlled size. REAS 
glasses are harder than window glass or vitreous silica. Vickers hardness is a measure of 
the hardness of a material, calculated from the size of an impression produced under load 
by a pyramid-shaped diamond indenter. The Vickers hardness of REAS glasses is 6~8 
GPa, while those of window glass and vitreous silica are less than 6 GPa. One 
application of REAS glasses is the treatment of primary hepatocellular carcinoma (liver 
cancer) with radioactive (90Y) yttria aluminosilicate (YAS) glass microspheres 
(TheraSphereTM). YAS microspheres are injected into the liver via the hepatic artery to 
deliver a therapeutic dose of beta radiation to the tumors (Salem et al. 2002). Injection of 
142Pr glass microspheres into arteriovenous malformation (AVM) feeding arteries was 
suggested by Mawad and Reece (Reece 2005) to treat arterial diseases and save healthy 
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tissues from undesirable exposure from high-dose radiation. Microspheres 53 µm in 
diameter were injected into the kidney of pigs. The microspheres occluded the arteries 
well while sparing healthy cells in the kidney. 142Pr microspheres have been studied for 
the treatment of arteriovenous malformations, and the effects of the arterial size and 
microsphere size to dose profile were evaluated (Lee and Reece 2005).  
 
I-2-3 Biological factors 
Several biological factors such as α/β ratio or biological effective dose (BED) 
have been extensively studied. One study (Brenner et al. 2002) suggested that external 
beam therapy with hypofractionation or high dose rate (HDR) brachytherapy is more 
effective in tumor control and late sequelae in the treatment of prostate cancer. The dose 
delivery time is closely related to the half-life of the radionuclide used in the 
brachytherapy seeds, but the tumor growth rate should be considered. To deliver dose to 
tumor effectively, the effect of half-life of the nuclide for permanent seed implants has 
been studied. Armpilia et al. (2003) suggested the optimum half-life as 4 ~ 17 days. This 
was based on the effectiveness of dose transfer considering initial dose rate, tumor 
repopulation factors or other biological factors.  
After radioactive seeds are implanted in the prostate, tumor cells and normal 
tissue will be killed. The death of cells near seeds induces shrinkage of prostate volume. 
This causes migration of seeds resulting in differences from pre-planned dose 
distribution in the prostate. The shrinkage rate is known to be 3.9×10-3 day-1 (Dale and 
Jones 1999), so shrinkage effects are not significant for short half-life radioisotopes. A 
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clinical investigation showed that post-implant edema increased the volume of the 
prostate by factors which ranged from 1.33 to 1.96 (mean: 1.52). The edema half-life 
varied from 4 to 25 days (Waterman et al. 1998).  
 
I-2-4 AAPM TG reports  
The AAPM TG has suggested some practical guidelines for clinical physicists. 
The updated AAPM TG-43 report (Rivard et al. 2004) recommended a dosimetry 
protocol for interstitial brachytherapy sources and proposed standardized dosimetry 
parameters such as air-kerma strength, dose-rate constant, and geometry function. TG-43 
parameters are explicitly for low energy photon emitters such as 125I and 103Pd and beta-
emitting sources were not included. TG-43 recommends that at least one experimental 
measurement and one Monte Carlo determination should be required for clinical 
application of the seed. The AAPM TG-60 report (Nath et al. 1999) addressed 
intravascular brachytherapy physics and included dosimetry recommendations for beta 
emitters. The AAPM Task Group Report No. 55 (TG-55) generally addresses 
radiochromic film dosimetry and suggests specific procedures for using radiochromic 
films. The AAPM Task Group Report No. 64 (TG-64) gives an overall description of 
permanent prostate seed implant brachytherapy including dose uniformity and 
conformity in the prostate.  
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I-3 Research need 
I-3-1 Conventional method  
The conventional treatment method is to implant many tens of 125I or 103Pd seeds 
into the prostate. To insert seeds into the prostate, ultrasound-guided transperineal 
template implant procedures are used shown in Figure I-4. The typical template has a 13 
by 13 matrix with 5 mm spacing. The needle for seed insertion is 21 cm long. The 
ultrasound probe usually enables doctors to guide the needle.  
 
 
Figure I-4. Ultrasound-guided transperineal template implant (Khan 2003) 
 
Considering that the mean free path of 22 and 28 keV photons in tissue is ~ 1.5 
and 2.5 cm, respectively, some seeds can contribute significant doses to the urethra and 
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rectal walls. Although low energy photon sources such as 125I and 103Pd have a long 
history, side effects such as painful urination and damage to the rectal and bladder walls 
are common. To reduce undesirable dose to adjacent organs, we propose using a beta 
source for the brachytherapy treatment of prostate cancer.  
 
I-3-2 Beta sources 
While beta sources such as 90Y, 188Re, and 32P have been used for vascular 
brachytherapy, beta sources have not been widely used for cancer therapy. Nevertheless 
beta sources offer several advantages over photon sources. Beta particles have short 
range and are easily shielded, lowering extraneous dose to medical staff as well as the 
patient. They can give a lower dose to the rectum and urethra than low energy photons 
from 125I and 103Pd. Knowing the continuous distribution in energy of the emitted 
electrons during beta-decay, the range and energy deposited in water or tissue can be 
determined using the electron stopping power relations. The range of a 2-MeV electron 
is 100 cm in air and 0.95 cm in water. The range R in g cm-2 in low-Z material for 
electrons (Turner 1995) can be expressed as  
 
For  0.01  ≤  T  ≤  2.5 MeV                                                                               (1-1) 
         TTR ln0954.027.1412.0 −⋅=
 
For  T  >  2.5 MeV                                                                                            (1-2) 
106.0530.0 −⋅= TR  
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Figure I-5 shows the comparisons of radial dose function, g(r) of 125I (Rivard 
2002) and 90Sr/90Y (Roa et al. 2002). The radial dose function, g(r) suggested in AAPM 
Task Group Report No. 43 (TG-43) accounts for dose fall-off on the transverse-plane. 
The radial dose function for 125I is flat to 2 cm and decreases gradually to 10% at 10 cm, 
while the radial dose function for 90Sr/90Y falls off to 0.1% at 0.8 cm. They are both 
normalized to 2 mm. 
 
0.1 1 100.2 0.5 2 5
distance (cm)
1.0x10-2
1.0x10-1
1.0x100
g(
r)
90Sr/Y, Roa et al 2002
125I, Rivard 2002
 
Figure I-5. Radial dose functions of 90Sr/90Y and 125I seed 
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I-4 Objectives 
The present study is to develop a detailed brachytherapy scheme for prostate 
cancer using beta emitting glass seeds. The method is to select appropriate isotopes and 
dimensions for brachytherapy, to produce brachytherapy seeds through glass seed design 
using neutron activation, to estimate dose distribution both with Monte Carlo 
computational calculation and experimental measurement using radiochromic films, and 
to provide AAPM TG-43/60 dosimetric parameters.  
 
I-5 Outline of the study 
This research was organized in four parts: isotope selection and seed design, 
Monte Carlo computational calculation, experimental measurement, and generation of 
AAPM TG-60 dosimetric parameters. As described in TG-43, one Monte Carlo 
calculation and one experimental measurement were performed. The results from 
computational dose calculation and dose measurement were compared and analyzed. 
Figure I-6 shows the scope of this research. 
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Figure I-6. Scope of research 
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CHAPTER II 
BIOLOGICAL MODELS 
 
II-1 Prostate anatomy and functions  
The prostate is one of the male reproductive organs. The prostate produces milky 
fluid which is added to semen. The function of the prostate is to facilitate movement of 
spermatic fluid to the uterus. If the prostate is diseased and reproduction is not an issue, 
the prostate can be removed because it is not a life-sustaining organ. The etiological 
cause of prostate cancer is not well known but thought to be due to hormonal or 
hereditary effects. The anatomy of the prostate is shown in Figure II-1. The volume of 
the prostate is 30 ~ 50 cm3 and is shaped like a chestnut. The size and shape varies each 
day. The organs adjacent to the prostate are the urethra, rectum, bladder, and seminal 
vesicles. The urethra is an approximately 4-mm diameter tube penetrating the center of 
prostate through which urine and semen exit. The urinary bladder is located cranial to 
the prostate. Seminal vesicles secrete fluid which forms part of the semen. The rectal 
wall is located 2 cm dorsal to the prostate.  
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Source:http://www.dva.gov.au/media/publicat/2001/prostate/pdf/You_an
d_Your_Prostate2006_complete.pdf 
 
Figure II-1. The anatomy of prostate  
 
II-2 Prostate cancer diagnosis 
Prostate cancer can be diagnosed by several tests, the most general of which is 
PSA blood testing. Prostate-specific antigen is an enzyme secreted by the prostate. If the 
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amount of secreted PSA is larger than 4 ng/ml, the prostate is suspected to be abnormal. 
Rectal palpation of the prostate is used to evaluate it for hardness or asymmetry. Biopsy 
is the most definitive test. If prostate cancer is diagnosed, Gleason scores can predict the 
quality of prostate cancer. Figure II-2 shows 5 different Gleason scores. A score of 1 is 
the least aggressive and 5 is the most aggressive. Gleason score grades the status of 
cancer and it is related to the tumor progression.  
 
 
 
Figure II-2. Gleason Score (Gleason et al. 1974) 
 
Table II-1 presents the categorization of prostate cancer. Prostate cancer is 
categorized as T, N, and M states. T state is primary tumor, N state is region lymph 
nodes invasion, and M state is distant metastasis. National Comprehensive  Cancer 
Network (NCCN 2005) has suggested clinical practice guidelines. According to these 
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guidelines, if a Gleason score is small and the stage is earlier than T2, prostate 
brachytherapy can be used effectively. If the prostate cancer progresses further than 
these criteria, another treatment option should be considered. 
 
Table II-1. Categorization of prostate cancer (NCCN 2005) 
Primary Tumor (T) 
Stage Description 
TX 
T0 
T1 
 
T2 
T3 
T4 
Primary tumor cannot be assessed 
No evidence of primary tumor 
Clinically inapparent tumor neither palpable nor visible 
by imaging 
Tumor confined within the prostate 
Tumor extends through the prostatic capsule 
Tumor is fixed or invades adjacent structures other than 
seminal vesicles 
Regional Lymph Nodes (N) 
Stage Description 
NX 
N0 
N1 
Regional lymph nodes were not assessed 
No regional lymph node metastasis 
Metastasis in regional lymph node 
Distant Metastasis (M) 
Stage Description 
MX 
 
M0 
M1 
Distant metastasis cannot be assessed (not evaluated by 
any modality) 
No distant metastasis 
Distant metastasis 
  
II-3 Radiosensitivity of prostate cancer 
Survival curves shown in Figure II-3 have been used for quantification of the 
susceptibility or sensitivity of radiation to cells or organs. The linear-quadratic (LQ) 
model has been used for the survival curve. The expression for the cell survival curve is  
2DDeS βα −−=                                                                                                   (2-1) 
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where S is the fraction of cells surviving a dose D, and α and β are constants. α is 
logarithmic survival constant proportional to dose and β is logarithmic survival constant 
proportional to the square of the dose. The ratio of α over β is used to quantify the 
fractionation sensitivity of a cell or organs. If the α/β ratio is small, which means β is 
relatively large, the survival curve bends downward quickly and the quadratic 
contribution is dominant (Hall and Giaccia 2006).  
 
 
Figure II-3. Survival curve (Hall et al. 2006) 
 
II-4 Biological effective dose 
While the prescribed doses using 125I and 103Pd are known based on empirical 
clinical data (144 Gy and 125 Gy respectively), the prescribed dose for 142Pr is not 
known. 
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Even though the same amount of total dose is deposited to a tumor or normal 
tissue, the biological effective dose (BED) for each radionuclide can be different from 
the physical dose due to the tumor doubling time, initial dose rate, tissue repair constant, 
relative biological effectiveness (RBE) or other biological factors. The BED based on 
the LQ model was expressed by Dale (1996) as 
BED = -ln(S)/α                                                                                                 (2-2) 
By combining Equation (2-1) and (2-2), the BED can be expressed as 
1(1 )BED D Dβ α
= +                                                                                            (2-3) 
In addition, considering the relative biological effectiveness (RBE), the BED is 
regarded as the prescribed dose times the relative effectiveness factor minus biological 
equivalent as given below in Equations (2-4) - (2-12) suggested by Antipas et al. (2001). 
BED = TD⋅RE – BRF                                                                                       (2-4) 
Where, TD is the total physical dose delivered and RE is the relative effectiveness factor, 
and BRF is the biological equivalent of the tumor repopulation. 
)]exp(1[0 effT
RTD λλ −−=                                                                                   (2-5) 



−=
0max
ln1
RRBE
KTeff λ                                                                                   (2-6) 
)(
))((
2 0
max CBA
RRBERE
tumtum
tum −


−+= βαλµ
λ                                             (2-7) 
)exp(1
1
effT
A λ−−=                                                                                            (2-8) 
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λ
λ
2
)2exp(1 effTB
−−=                                                                                          (2-9) 
λµ
λµ
+
+−−=
tum
tumeffTC
)](exp[1
                                                                            (2-10) 
efftum TKBRF ⋅=                                                                                               (2-11) 
avT
K ⋅= α
693.0                                                                                                         (2-12) 
 
where, 
          R0 = initial dose rate (Gy/h) 
          λ = radionuclide decay constant (h-1) 
          Teff = effective treatment time (h) 
          K = tumor repopulation factor (Gy/h, Gy/day), the biologic dose required 
to offset each day’s worth of tumor repopulation 
          RBEmax = the maximum RBE, defined as the ratio of linear sensitivity 
coefficient (α) with the high-LET test radiation to that for a reference (low-LET) 
radiation  
          µtum = sublethal damage repair constant (h-1) 
          (α/β)tum =  inverse of the fractionation factor of the tumor (Gy) 
          α = linear radiosensitivity coefficient (Gy-1) 
          Tav =  average clonogen doubling time 
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Because the shrinkage rate is known to be small, 3.9×10-3 day-1 (Dale et al. 1999), 
shrinkage effects are not considered. 
 
Table II-2. Tumor BEDs of several nuclides with α = 0.1 Gy-1 and Tav = 60 days 
µ (tumor) 
(h-1) 
α/β (tumor) 
(Gy) 
BED 
(125I : 144 Gy) 
BED 
(103Pd : 125 Gy) 
BED 
(142Pr : 90 Gy) 
Assuming RBEmax = 1.0 for all nuclides 
0.5 
0.5 
0.5 
0.5 
0.5 
10 
7 
5 
2.5 
1.5 
110.2 
111.0 
112.2 
116.2 
121.5 
116.8 
119.0 
122.1 
132.7 
146.8 
143.9 
167.3 
198.6 
308.2 
454.2 
RBEmax = 1.45 (125I , 142Pr) and 1.75 (103Pd ) 
0.5 
0.5 
0.5 
0.5 
0.5 
10 
7 
5 
2.5 
1.5 
171.7 
172.6 
173.7 
177.7 
183.1 
208.9 
211.2 
214.2 
224.8 
239.0 
184.3 
207.8 
239.1 
348.6 
494.6 
RBEmax = 1.0 
1.4 
1.4 
1.4 
1.4 
1.4 
10 
7 
5 
2.5 
1.5 
108.9 
109.2 
109.6 
110.0 
112.9 
113.4 
114.2 
115.3 
119.0 
124.1 
109.6 
118.3 
130.0 
170.9 
225.4 
RBEmax = 1.45 (125I , 142Pr) and 1.75 (103Pd ) 
1.4 
1.4 
1.4 
1.4 
1.4 
10 
7 
5 
2.5 
1.5 
170.4 
170.7 
171.1 
172.6 
174.5 
205.5 
206.3 
207.4 
211.2 
216.3 
150.0 
158.8 
170.5 
211.4 
265.9 
 
Table II-2 presents tumor BEDs of several nuclides. As shown in Table II-2, 90 
Gy of 142Pr gives the equivalent BED of 144 Gy of 125I and 125 Gy of 103Pd. Thus 90 Gy 
of 142Pr is suggested as the prescribed dose based on the sensitivity analysis of dose of 
142Pr and the BED comparison.  
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Table II-3. BEDs with typical radionuclides for different parameters  
K (Gy/day) 
α/β (Gy) 
Isotope (T1/2) 
0.01 
3.5 
 
0.1 
3.5 
 
0.1 
1.5 
 
0.6 
10 
 
0.9 
10 
 
142Pr (19.12 h) 92.5 91.8 151.2 60.0 58.6 
198Aua (65 h) 95.1 93.0 129.7 67.3 63.6 
131Csa (233 h) 96.9 90.8 107.3 62.0 53.0 
103Pda (407 h) 97.0 87.4 98.0 52.0 40.1 
125Ia (1426 h) 94.7 70.2 73.6 13.6 2.5 
aArmpilia et al. 2003 
 
Biological factors such as α/β ratio and K are not certain. The sensitivity 
calculation results of various factors are presented in Table II-3. The most probable 
parameters are used. Recent studies suggest that the α/β ratio ranges from 1.5 to 5 and K 
is between 0.01 and 0.9. The BEDs of 142Pr are reasonable compared to other typical 
radionuclides.  
Figure II-4 shows the sensitivity of α/β ratio. As the α/β ratio increases, the BED 
for 142Pr decreases exponentially. The BEDs for 125I and 103Pd are relatively insensitive 
to α/β ratio because the initial dose rate greatly contributes to the BED. 
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Figure II-4. Biological effective dose as a function of α/β ratio. µ = 0.5 h-1, RBEmax = 1, 
α = 0.1 Gy-1 and Tav = 60 
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Figure II-5. Biological effective dose as a function of K with α/β ratio of 5. µ = 0.5 h-1, 
and RBEmax = 1 
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As tumor repopulation factor increases, the BEDs of 103Pd and 125I fall off 
sharply because of their long half-life as shown in Figure II-5. The BED of 142Pr is 
insensitive to tumor repopulation factor. Therefore, 142Pr is acceptable for treating 
tumors with high K’s and low α/β ratios.  
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CHAPTER III 
ISOTOPE SELECTION AND SEED DESIGN 
 
III-1 Conventional seed  
Several seeds using 125I or 103Pd have been used for the treatment of prostate 
cancer. Several companies such Theragenics Corp., Amersham, Best Inc., and others 
have developed and, over time, improved brachytherapy seeds. The price of the seeds is 
from $50 to $150 per seed. More than 50 seeds are typically used during a single 
treatment. The shapes of several seeds are posted on the AAPM RPC seed registry (RPC 
2006) and shown in Figure III-1. The dimensions of typical seeds are ~ 5 mm long and 
0.8 mm in diameter to fit within established urologic implantation devices such as 
template-guided needle delivery systems. Most of them have radiation opaque markers 
and titanium encapsulation. The titanium cladding is 0.04 mm - 0.06 mm thick. Gold or 
silver is used as the radiation opaque marker. Typical seed strengths are on the order of 
0.3 mCi for 125I for permanent prostate implants. Some of seeds consist of several of 125I 
or 103Pd beads inside the titanium cladding. 
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(a) Amersham OncoSeed model 6711               (b)  I-Plant model 3500 
 
         
(c) Ibt Intersource125 model 1251L           (d) THERASEED model 200 
 
                  
(e) Prospera Med 3633                        (f) OptiSeed model 1032P 
 
 
 
Figure III-1. Brachytherapy seeds (RPC 2006) 
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III-2 Isotope selection criteria 
Although over one hundred seeds are sometimes used to treat the prostate, we 
assumed fifty seeds for a typical implantation to lessen surgery time. If 50 seeds are used 
and the prostate is 50 g and 50 cm3, 1 seed should cover 1 cm3 of prostate volume and 
we should get the target dose at about 0.6 cm from the center. The target dose selected 
for this study is 150 Gy. This value is selected conservatively based on 144 Gy for 125I 
and 125 Gy for 103Pd. We seek to achieve this target dose using a radionuclide that 
produces high-energy beta particles because we believe that adjacent tissues can be 
spared unnecessary dose.  
 
III-3 Seed design criteria 
We want the seeds to be activated in a low thermal neutron fluence rates typical 
of research reactors so the neutron absorption cross section should be large enough to 
make sufficient activity easily in these neutron fields. As discussed earlier, a 
radionuclide with short half-life for high dose rate irradiation is acceptable. The seeds 
should have chemical, mechanical, and biological integrity during neutron activation and 
in vivo. The cost of manufacture of these seeds should be relatively inexpensive. Finally 
the seeds should be visible during seed implant and post-implant monitoring with or 
without radiation opaque markers.  
 
27 
 
 
III-4 Neutron activation analysis 
The isotope 142Pr will be made in a low neutron fluence reactor such as research 
reactor. The target activities can be easily controlled by knowing the neutron fluence 
rates, neutron activation time, mass of target nuclide per seed, and neutron absorption 
cross section. The activity at end of activation can be expressed as 
 
0(1 )tm wt abunA Av eM
λσ φ −⋅ ⋅= ⋅ ⋅ ⋅ ⋅ −                                                            (3-1) 
 
where, 
          A = activity (dps, Bq) 
          m = total mass of seed (g) 
          wt = weight percent of element 
          abun = abundance of isotope 
          M = atomic mass of isotope (g) 
          Av = Avogardo’s number 
          σ =  neutron capture cross section (barn, 10-24 cm2) 
          φ = neutron flux (cm-2sec-1) 
          λ = decay constant (sec-1) 
          t0 = neutron activation time (sec) 
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III-5 DPK code description 
To get the preliminary dose distribution, BRAIN-DOSES code was used (Dauffy 
1998). BRAIN-DOSES code is based on SADDE (Reece et al. 1989) and VARSKIN 
(Traub et al. 1987) codes. SADDE is a code to generate input from the calculated beta 
spectra for VARSKIN. The following inputs for SADDE were needed. 
 
1. the isotope name 
2. whether to include multiple isotopes 
3. the number of decay paths for this radionuclide 
4. the atomic number of the transition nucleus 
5. the atomic mass of the parent nucleus 
6. the endpoint beta energy in MeV 
7. the fractional yield 
8. the forbiddenness for the particular decay 
9. the number of internal conversion and Auger electrons for this radionuclide 
 
The output was added to betadata.dat file for VARSKIN code. Table III-1 and 
III-2 present the inputs and outputs for several beta emitters. 
29 
 
 
Table III-1. Examples of input decks for SADDE Mod 2 (Reece et al. 1989) 
90Y 142Pr 188Re 32P 
Y-90 
N 
1 
40. 
90. 
2.2792 
0.99984 
1 
0 
Pr-142 
N 
1 
60. 
142. 
2.1622 
0.963 
1 
0 
Re-188 
N 
1 
76. 
188. 
2.120 
0.967 
1 
0 
P-32 
N 
1 
16. 
32. 
1.709 
1.0 
1 
0 
 
BRAIN-DOSES integrates the Berger point kernels over the source volume, 
employing the scaled point kernels tabulated by Berger in 1971. Dose point kernel 
(DPK) codes are fast and have good agreement in simple geometries when compared 
with Monte Carlo calculation. The Berger beta dose point kernel can be expressed as  
 
                         ∫= max0
9090
2 ),(
)(
4
1),(
E
dEE
X
F
X
EENEB ρπδρρ                                   (3-2) 
 
where, ρ is the distance between source point and dose point (cm), δ is the density of the 
irradiated medium (assumed to be unity for tissue) (g/cm3), N(E) is the probability 
density of fluence, X90 is the radius of the sphere within which 90% of the beta energy is 
deposited from a point source in a finite medium (cm), and F is the dimensionless scaled 
absorbed dose distribution as a function of the modified path length and the X90 distance. 
BRAIN-DOSES was developed for 5 different source geometries: point, line, shell 
cylinder, solid cylinder and solid sphere. Table III-3 presents the output of BRAIN-
DOSES for a 142Pr glass seed. 
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Table III-2. Examples of output data for SADDE Mod 2 
90Y 
Y-90    
      0.9367  0.5170  1.0000  
     1.3300 1.2900 1.2500 1.2200 1.2000 1.1800 1.1900 1.1800 1.1600 1.1300  
     1.1000 1.0700 1.0300 0.9900 0.9400 0.8900 0.8400 0.7900 0.7400 0.6900  
     0.6300 0.5800 0.5200 0.4700 0.4100 0.3100 0.2200 0.0800 0.0200 0.0000  
0 
142Pr 
Pr-142 
       .8375   .4878  1.0010 
     1.4232 1.3965 1.3698 1.3442 1.3257 1.3150 1.2706 1.2310 1.1941 1.1536 
     1.1117 1.0726 1.0294  .9854  .9402  .8925  .8434  .7925  .7400  .6861 
      .6312  .5755  .5196  .4640  .4093  .3053  .2127  .0775  .0147  .0005 
      1 
      1575.   0.325 
188Re 
Re-188 
       .7186   .4370  1.0992 
     2.3837 2.1544 1.9251 1.6958 1.6802 1.6297 1.3599 1.3393 1.3135 1.2787 
     1.2365 1.1893 1.1366 1.0803 1.0234  .9634  .9018  .8395  .7767  .7137 
      .6512  .5895  .5291  .4705  .4143  .3108  .2218  .0930  .0266  .0038 
      0.0     0.0 
32P 
P-32   
       .7217   .3765  1.0000 
     1.2678 1.2527 1.2376 1.2239 1.2185 1.2149 1.2022 1.1872 1.1712 1.1482 
     1.1202 1.0852 1.0459 1.0023  .9573  .9089  .8583  .8059  .7522  .6974 
      .6415  .5847  .5276  .4709  .4151  .3087  .2140  .0764  .0140  .0004 
      0.0     0.0 
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Table III-3. Examples of output for BRAIN-DOSES 
 
Program BRAIN_DOSES 
 
Pr-142 9L, 0.8D                                                                  
 
      2-D Cylindrical Source Geometry 
  
  
                Nuclide :     Pr-142 
       1.8*X90 Distance :     0.878040 cm 
            No gamma dose calculation 
        Source Strength :     1.00000 uCi 
         Source Density :   0. g/cm^3 
       Diameter of Disk :     800.000 um 
         Relative Error :     1.00000E-04 
 
 Calculated Results: 
 
    Radial          Dose  
   Distance         Rate  
     (cm)         (rad/h) 
   --------      --------- 
    0.0000        9.89E+01        8.13E-02 
    0.0400        1.39E+01        1.33E-02 
    0.0800        7.68E+00        7.88E-03 
    0.1200        4.92E+00        5.41E-03 
    0.1600        3.37E+00        4.00E-03 
    0.2000        2.39E+00        3.09E-03 
    0.2400        1.73E+00        2.46E-03 
    0.2800        1.26E+00        2.00E-03 
    0.3200        9.20E-01        1.66E-03 
    0.3600        6.65E-01        1.39E-03 
    0.4000        4.74E-01        1.19E-03 
    0.4400        3.31E-01        1.02E-03 
    0.4800        2.25E-01        8.85E-04 
    0.5200        1.47E-01        7.73E-04 
    0.5600        9.19E-02        6.80E-04 
    0.6000        5.42E-02        6.03E-04 
    0.6400        2.97E-02        5.37E-04 
    0.6800        1.47E-02        4.80E-04 
    0.7200        6.34E-03        4.32E-04 
    0.7600        2.20E-03        3.90E-04 
    0.8000        5.39E-04        3.54E-04 
    0.8400        7.11E-05        3.22E-04 
    0.8800        0.00E+00        2.94E-04 
    0.9200        0.00E+00        2.69E-04 
    0.9600        0.00E+00        2.47E-04 
    1.0000        0.00E+00        2.28E-04 
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III-6 Nuclide comparison 
Several candidate radionuclides were considered for seed production. Figure III-
2 shows the radial dose profiles of various beta emitters from the BRAIN-DOSES code 
as a function of distance from the surface of the seed at seed midpoint. The dose profiles 
are mainly dependent on the range of the beta particles. 
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Figure III-2. Radial dose profiles of several beta emitters 
 
 
Yttrium and phosphorus have been used for intravascular brachytherapy. 90Y 
glass microspheres have been used for hepatocellular carcinoma. But 90Y has a small 
thermal neutron absorption cross section and 32P produces relatively low energy beta 
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particles. Rhenium has a large neutron cross section but it is not easily incorporated into 
glass because of its volatility. Table III-4 compares the properties of several beta 
emitters. Because the dose profile of 142Pr decreases more rapidly than that of 90Y, as 
seen in Figure III-2, 142Pr is more useful for intravascular brachytherapy treatment in 
which a high localized dose is needed around the blood vessel. 
 
Table III-4. Properties of several beta emitters 
 
Property 142Pr 90Y 188Re 186Re 32P 
Half life 19.12 h 64.0 h 17.0 h 90.6 h 14.28 d
Maximum beta 
energy (MeV) 2.162 2.281 2.118 1.071 1.709 
Abundance 1.000 1.000 0.626 0.374 1.000 
Weight Percent 
in glass 0.445 0.4 0.3 0.3 0.25 
Density of glass 
(g/cm3) 4.0 3.29 2.9 2.9 3.06 
Gamma 
emissions for 
imaging 
1.58 MeV, 
γ(3.7%) Brems
a 155.0 keV, 
γ(15%) 
137.2 keV, 
γ(9.5%) Brems
a
Thermal neutron 
cross section 
7.5 b 
(+3.9b)b 1.28 b 73 b 112 b 0.17 b 
a Bremsstrahlung.  
b Cross section of meta-stable state.  
 
 
 
34 
 
 
III-7 Properties of 142Pr 
Based on neutron activation analysis and BRAIN-DOSES calculations, 142Pr was 
selected as the most appropriate isotope. It is a rare earth material suitable for REAS 
glass and a sufficiently large cross section of 7.5 barns (+3.5 barn of meta-stable state) 
for activation in research reactors. 142Pr is made by neutron activation of the 100% 
abundant 141Pr, producing both the 19.12 hour ground state and 14.6 min meta-stable 
state. The 142Pr ground state decays emitting 2.162 MeV endpoint energy beta rays 
96.3 % of the time and has a 3.7% yield of 1.575 MeV gamma rays. With a 19.12 h half 
life, 90% of the dose (D90) is deposited in 2.65 days. Figure III-3 shows the beta 
spectrum of 142Pr. This data was obtained from http://ie.lbl.gov. 
 
 
Figure III-3. Beta spectrum of 142Pr 
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Figure III-4 shows the decay scheme of 142Pr from http://atom.kaeri.re.kr/ton. 
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Figure III-4. Decay scheme of 142Pr 
 
 
III-8 142Pr REAS glass seeds 
142Pr REAS glass seeds have several advantages over conventional seeds. The Pr 
seed is economical; it costs less than 15 dollars per seed including materials and neutron 
activation costs. Due to the short range of beta particles, the dose to adjacent organs can 
be minimized with optimized implantation positions of the seeds. Because of the short 
half-life of 142Pr, and associated high dose rate, distortion of the prostate during 
irradiation is less than with 125I, for example, that has a D90 of 204 days. Pr seeds can 
have very high dose rates, if desired, and give doses up to thousands of Gy to tumors 
near seeds. Because of high density and high atomic number of Pr glass, a radio-opaque 
marker is not necessary. Cladding or encapsulation is not required because the seed is 
unreactive in water or tissue. Variable sizes and shapes of glass seeds can be made and 
the seed is not easily broken. The seed is reusable after a high dose rate (HDR) treatment 
by reactivation.  
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CHAPTER IV 
MONTE CARLO COMPUTATIONAL MODELING 
 
Radiation interaction is basically a stochastic process. Monte Carlo method is a 
statistical method to predict the behaviors of individual particles using cross sections for 
all interaction processes. Cross sections are randomly sampled to determine type of 
interaction that will occur, distance to that interaction, energy transferred, new direction 
of particle and distance to next interaction.  
 
IV-1 MCNP Monte Carlo code 
The MCNP5 code was used to calculate the quantitative dosimetric parameters of 
the Pr seeds. MCNP is a general-purpose Monte Carlo code. It can be used for neutron, 
photon, electron, or coupled neutron/photon/electron transport with the default modeling 
of secondary radiations such as positrons, K-edge characteristic x-rays, and 
bremsstrahlung. It can model an arbitrary three-dimensional geometry and various 
source types such as point, volume, and surface with user-defined source spectrums. A 
continuous-slowing-down model expressed as equations (4-1, 2) is used for electron 
transport. (X-5 Monte Carlo Team 2003).  
In MCNP, the energy and path lengths of electron transport are modeled by 
 
∫ −−=−− nnSSnn dsdsdEEE 11                                                                                     (4-1) 
37 
 
 
 
where En, Sn, and -dE/ds are energy, the total path length, and the total stopping power in 
energy per unit length. 
The electron collisional stopping power due to collisions between particles and 
atoms is from the Berger’s formulation: 
24
2 2
2
2 ln[ ( 2)] 2 3 4
1col
dE eNZ C C C
ds m v
π ττ τ β τ δ
 ⋅     − = + − + − + −    +     
       (4-2) 
where,C ),2ln(2 2I= ,2ln13 −=C 2ln
8
14 +=C .  
Here N is the atom density of the medium in cm-3; Z is the average atomic 
number of the medium; m, e, and v are the rest mass, charge, and speed of the electron, 
respectively; t is the electron kinetic energy in units of the electron rest mass 
The electrons partly lose their energy by radiative interactions with the Coulomb 
force field of atom. The electron radiative stopping power is modeled as  
Φ++=− )(22
_
24 ))()((10 nrade
rad
mcTrZZ
ds
dE αη                                               (4-3) 
where, η is a parameter to account for the effect of electron-electron bremsstrahlung, α 
is the fine structure constant, re is the classical electron radius and Φ  is the scaled 
electron-nucleus radiative energy-loss cross section based upon evaluations by Berger 
and Seltzer. 
)(n
rad
As beta particles interact with matter, statistical variations occur in the amount of 
energy in each collision. The statistical variation of energy losses is called energy 
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straggling (Turner 1995). Landau/Blunck-Leisegang theory expresses energy straggling 
due to collisions as   
λλφ ddsf )(),( =∆∆ ,                                                                                        (4-4) 
where s is the length of the substep, ∆ is energy loss, and φ(λ) is a universal function of a 
single scaled variable. 
 
The angular deflection is sampled for each substep. The Goudsmit-Saunderson 
theory is used for precalculation and tabulation of multiple scattering distributions at the 
initiation of a run.  
∑∞
=
−

 +=
0
)()exp(
2
1),(
l
ll PsGlsF µµ ,                                                               (4-5) 
where s is the length of the substep, µ = cos θ is the angular deflection from the 
direction at the beginning of the substep, Pl(µ) is the lth Legendre polynomial, and Gl is 
[ ]1
1
2 1 ( )l
dG N P d
d l
σπ µ+−= −Ω∫ µ ,                                                                       (4-6) 
in terms of the microscopic cross section dσ/dΩ, and the atom density N of the 
medium. 
The sampling of bremsstrahlung photons produced is simulated along electron 
substeps. The radiative energy loss uses the average energy of all the bremsstrahlung 
photons sampled. Such a scheme conserves energy more closely but becomes more like 
a continuous-slowing-down approximation energy-loss model. 
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Beta particles lose their energy through several processes at the same time or 
with a slight time difference. For the computation sequence, the transport data of 
particles in each substep may not be equal to the actual data in a substep. To compensate 
for this discrepancy, MCNP adopts the two energy indexing algorithms: MCNP energy-
indexing algorithm and ITS energy-indexing algorithm. The MCNP energy-indexing 
algorithm uses the precalculated transport data from the initial energy group, while the 
ITS energy-indexing algorithm assigns the data from the average energy group. Schaart 
et al. (2002) compared computational results of two energy indexing algorithms with 
experimental results. ITS electron energy-indexing algorithm agreed with the 
experimental results more closely. 
The detailed modeling not addressed here is described in MCNP5 manual (X-5 
Monte Carlo Team 2003). 
 
IV-2 Code modeling 
The MCNP5 base model for the glass seed was developed consisting of 3 cells, 
181 surfaces, and 177 detector cells. The *F8 tally (an energy deposition tally, with units 
of MeV) in a 0.01 cm radius spherical water receptor was used to calculate dose per unit 
activity at varying distances. Dose can be calculated as *F8 tally divided by mass of 
detector cells. An “ITS-style” energy-indexing algorithm (Jeraj et al. 1999) was used 
and the number of source electron histories was chosen so that there was less than 1% of 
statistical error at the reference point. Mode P E was used with default modeling of 
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bremsstrahlung.  Figure IV-1 shows the MCNP drawings denoting the seed and 
detectors in water on x-y plane, and y-z plane. 
 
 
a) x-y plane 
 
 
b) y-z plane 
Figure IV-1. MCNP drawings 
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IV-3 Calculation results 
The MCNP5 Monte Carlo code was used to calculate dose rate distributions in 
water. Dosimetry data in water were calculated in radial distances from the glass seed 
from 1 mm to 10 mm, and over angles ranging from 0o to 90o using *F8 tally in a 0.02 
cm diameter water receptor. Figure IV-2 shows radial dose profiles of DPK and MCNP5 
calculation. The profiles have a good agreement up to 0.6 cm but beyond 0.6 cm, the 
DPK code underestimates the dose.   
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Figure IV-2. Radial dose profiles of DPK and MCNP5 calculation 
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Figure IV-3 shows the comparison of radial dose profiles of various seeds. Even 
though the design and dimensions of the seeds are different, note that the dose profile of 
142Pr is in a reasonable range compared with those of other beta-emitting seeds.  For 
90Sr/90Y, the dose within 0.2 cm is much higher than with other seeds because of the 
dose contribution of 90Sr and the effects of the different seed dimensions. 
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Figure IV-3. Comparison of radial dose profiles of various beta emitters 
 
 
Figure IV-4 shows the radial dose profiles of beta and gamma dose from Pr seeds. 
The dose profile from beta decreases gradually to 0.6 cm because of low-energy part of 
the spectrum of beta particles and drops sharply after 0.6  cm (the range of average beta 
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energy). The dose profile is obviously also controlled by the inverse-square distance 
effects. The dose profile of gamma rays decreases gradually and the gamma dose is 
dominant beyond 0.9 cm. Calculations suggest that the dose at 1.0 cm from the source 
with initial activity of 5.95 mCi is 2.7×10-4 Gy/h.  
 
0 0.2 0.4 0.6 0.8 10.1 0.3 0.5 0.7 0.9
distance (cm)
1.0x10-5
1.0x10-4
1.0x10-3
1.0x10-2
1.0x10-1
1.0x100
1.0x101
Do
se
 ra
te
 (r
ad
/h
r/µ
C
i)
beta
gamma 
 
 
Figure IV-4. Radial dose profiles of beta and gamma dose of 142Pr 
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IV-4 Uncertainty analysis 
Table IV-1 presents an uncertainty analysis for the calculations performed. On 
the transverse-plane the statistical uncertainties in water at 0.2 cm and 0.6 cm were 
0.3 % and 1.0 % respectively.  
 
 
Table IV-1. Uncertainty assessment for Monte Carlo calculations 
Monte Carlo uncertainties 
Component r = 0.2 cm r = 0.6 cm 
Statistics 
Cross-sections (2.3 %) 
Seed geometry 
Source energy spectrum 
 
Quadrature sum 
0.3 % 
 
2.0 % 
1.56 % 
 
3.4 % 
1.0 % 
 
2.0 % 
1.56 % 
 
3.6 % 
 
For the electron calculation, MCNP5 uses mcplib04 and el03 cross section 
libraries. They have 2.3% uncertainty in the cross-sections. Even though the energy 
spectrum is modeled using the A option in which the entries are monotonically 
increasing or decreasing between the points selected as the energy spectrum, it cannot be 
modeled exactly as the curve of energy spectrum. The average energy of the input is 
1.56% less than that of energy spectrum. The total quadrature sum uncertainty was 
estimated to 3.4 % for 2 mm and 3.6 % for 6 mm respectively.  
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IV-5 Sensitivity analysis 
A sensitivity analysis was performed to find the optimum size of the detector in 
MCNP calculations, the impact of seed length, and the effect of “ITS-style” energy 
indexing algorithm. Figure IV-5 shows the comparison of dose rate as a function of 
radius of detector. The output shows no significant differences below 0.01 cm radius. A 
smaller detector needs more computation time to get the same statistical uncertainty. The 
0.01 cm radius detector was selected for most calculations based on the resolution of the 
output and computation time.  
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Figure IV-5. Comparison of dose rate for different radii of the detectors 
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Figure IV-6 shows the radial dose profiles as a function of seed length with 
initial activity of 5.95 mCi. The radial dose profile does not vary significantly with the 
length of seed. 
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Figure IV-6. Radial dose profiles of different lengths of the seed 
 
Figure IV-7 shows the axial dose profiles as a function of seed length with initial 
activity of 5.95 mCi. The axial dose profile decreases as the seed length is shortened. If a 
0.45-cm length of seed is used, the radial and axial dose at 0.6 cm is expected to be same 
meaning that the dose profile of the seed is similar to an isotropic source. From this 
analysis, we may predict the dose distributions of longer seeds. The radial dose profile 
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will be about the same at the transverse-plane at any length longer than 4.5 cm length 
and the axial dose profile will be increased proportional to the length.  
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Figure IV-7. Axial dose profiles of different lengths of the seed 
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CHAPTER V 
EXPERIMENTAL MEASUREMENT 
 
V-1 Preparation of experiment 
The Pr Glass was manufactured by MO-SCI Corporation (Rolla, MO 65402). 
The glass comes in about 15.0 cm long rods as shown in Figure V-1. The rod diameter is 
0.08 ± 0.001 cm, the same as the typical 125I seeds. Because the rod is extruded from 
bulk glass, it may bend and be uneven. It is recommended that the glass rod be drawn to 
get more uniform diameter of the seeds. To cut the rods, a specially designed cutting tool 
was made using a DREMEL® tool which can cut the glass to the same length as shown 
in Figure V-2. The edges of the seed were smoothed with sandpaper. Figure V-3 shows 
the seed dimensions and coordinate system based on AAPM TG-43. The length is twice 
that of the typical 125I seeds to achieve the target dose at the edges of the field and to 
shorten surgery time. The density of Pr glass is 4.0 g/cm3 and the weight percent of Pr is 
44.5%. The refractory index of Pr glass is 1.705 ~ 1.715. Table V-1 presents the 
compositions of 142Pr REAS glass. The detailed material test sheet is listed in Appendix 
I. 
 
 
Figure V-1. Raw 142Pr REAS glass seed 
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Figure V-2. Specially designed DREMEL tools 
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Figure V-3. Seed dimensions and coordinate system 
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Table V-1. Compositions of 142Pr REAS glass seed 
Element Weight % Mass in seed 
(mg) 
Si 0.153  2.754  
Al  0.081 1.458 
Pr  0.445  8.010 
O 0.321  5.778 
Total 1.000 18.000 
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V-2 Nuclear Science Center Reactor (NSCR) 
The Pr glass seeds were activated in a TRIGA (Teaching, Research, and Isotopes, 
General Atomic) reactor.  The TRIGA reactor at Nuclear Science Center (NSC 2003) in 
Texas A&M University, College Station, Texas is a one-megawatt (MW) pool type 
nuclear reactor. Each location in the grid supports a fuel bundle with 4 positions for 
either fuel elements, control rods or other non-fueled elements. Figure V-4 shows the 
TRIGA core configuration including regular fuel elements, an instrumented fuel element, 
shim safety rods, a transient rod and a regulating rod.  
The fuel elements and control rods are contained in bundle assemblies which are 
positioned and supported by an aluminum grid plate containing a 6 by 9 array of holes. 
The grid plate accommodates graphite blocks, detectors, pneumatic devices and various 
experiments. The grid locations in column A on the grid plate are available for 
positioning various irradiation objects. The grid locations D3 and D7 are reserved for 
experiments that require fast neutrons or higher neutron flux. Pneumatic irradiation 
devices are installed for the production of short-lived radioisotopes. The irradiation cell 
located at the west end of the reactor pool is used to irradiate large objects. In this 
configuration, samples can be easily loaded and unloaded for long and short irradiations. 
The reactor operates at a maximum steady-state power level of 1 MW. At this level, the 
thermal neutron flux at various sample irradiation locations ranges from about 1.0×1012 
neutrons·cm-2s-1 to a maximum of 1.5×1013 neutrons·cm-2s-1. The information of research 
reactors worldwide is available at www.iaea.or.at/worldatom/rrdb. 
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Figure V-4. Current NSCR core configuration 
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V-3 Neutron activation 
For this experiment, the D7 location was used for neutron activation. Si and Al as 
well as Pr were activated in the reactor. However 28Al has a 2.24 minute half-life and 
31Si has 2.62 hours half-life with 0.07% yield of gamma rays. Table V-2 presents several 
isotopes that are made during a one hour neutron activation of 142Pr REAS glass at the 
D7 location. 
 
Table V-2. Isotopes from neutron activation of 142Pr REAS glass 
Isotope Activity Half-life Radiation Yield 
31Si 17.9 µCi 2.62 h γ 1.266 MeV 
β 1.48 MeV 
0.07 % 
100 % 
28Al 3.05 mCi 2.25 min γ 1.778 MeV 
β 2.863 MeV 
100 % 
100 % 
142Pr 4.384 mCi  19.12 h γ 1.575 MeV 
β 2.162 MeV 
3.7 % 
96.3 % 
142mPr 1.675 mCi 14.6 min ΙΤ 100 % 
19O 2.59 µCi 26.9 sec γ 1.365 MeV 
β 4.623 MeV 
50.4 % 
45.4 % 
 
Cd-covered gold foils and bare gold foils were used to measure the neutron 
fluence rate at the activation location. Because Cd has a high thermal neutron cross 
section, essentially all of the thermal neutrons are absorbed in Cd. The Cd-covered Au-
foil was almost solely activated by the epi-thermal neutron. The activities of Au-foils 
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were measured using a HPGe detector and the fluence rate of the thermal (2200 m/s) and 
epi-thermal neutrons was estimated to 1.481×1013 and 6.976×1011 cm-2s-1, respectively. 
Based on the neutron fluence rate measured with the gold foils, the activities of 
142Pr were calculated using neutron activation equations and measured with a HPGe 
detector. The HPGe detector is the most popular for evaluating a photon source because 
of its high resolution. A semiconductor detector acts as a solid-state ionization chamber. 
The ionizing particle-beta ray, alpha particle, etc.-interacts with atoms in the sensitive 
volume of the detector to produce electrons by ionization. The collection of these ions 
leads to an output pulse. In contrast to the relatively high mean ionization energy of 30 
to 35 eV for most counting gases, a mean energy expenditure of only 3.5 eV is required 
to produce an ionizing event in a semiconductor detector. 
Radiation spectroscopy is the analysis of radiation sources or radioisotopes by 
measuring the energy distribution of the source. A spectrometer is an instrument that 
separates the output pulses from a detector, usually a scintillation detector or a 
semiconductor detector, according to size. Since size distribution is proportional to the 
energy of the detected radiation, the output of the spectrometer provides detailed 
information that is useful in identifying unknown radioisotopes and in counting one 
isotope in the presence of others. This technique has found widespread application in X-
ray and gamma-ray analysis using NaI(Tl) scintillation detectors and semiconductor 
detectors, in beta-ray analysis using liquid scintillation detectors, and in alpha analysis 
using semiconductor detectors. Nuclear spectrometers are available in two types, either a 
single-channel instrument or a multichannel analyzer (MCA). The essentials of a single-
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channel spectrometer consist of the detector, a linear amplifier, a pulse-height selector, 
and a readout device, such as a scaler or a ratemeter.  
A multichannel analyzer has an analog-to-digital converter (ADC) instead of a 
pulse-height selector to sort all the output pulses from the detector according to height. 
The MCA also has a computer-type memory for storing the information from the ADC 
or from another source. This feature allows automated data processing operations such 
as background subtraction and spectrum stripping.  
Although 142Pr is mainly a beta source, HPGe detectors can detect 142Pr using 
gamma spectroscopy because it has a 3.7 % yield of 1.5 MeV photons. As shown in 
Figure V-5, the 142Pr glass seeds has prominent peak at 1.5 MeV after several half-lives 
of 142Pr. Table V-3 compares the calculated and measured activities. The activity was 
measured about 5 half-lives of 142Pr after end of neutron activation for 20 minutes with 
1.21% of dead time. The epi-thermal neutron flux was considered for the calculation. 
The induced activity of the 142Pr glass seeds was as predicted.   
 
 
Table V-3. Activity from measurement and calculation 
 Measurement
(HPGe) 
Calculation
(NAA) 
Activity 235.88 µCi 236.5 µCi
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Figure V-5. Energy spectrum of 142Pr at HPGe detector 
 
Figure V-6 shows the relative activity as a function of time after activation. The 
square is 142Pr activity from ground-state. The triangle is the activity from meta-stable 
state. The circle is the total activity. After about 3 half lives of 142mPr, the total activity is 
at maximum. After meta-stable decay, 36% of total activity is derived from the meta-
stable state. Immediately after activation, the 142Pr seed is too active to measure on the 
HPGe detector. We measured the activity after several half-lives of 142Pr passed and 
calculated the activity back to the end of neutron activation. 
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Figure V-6. Relative activity of 142Pr and 142mPr after end of neutron activation 
 
 
 
The activity of 142Pr and 142mPr can be expressed as 
i) 0 < t < t0 
11
1 NR
dt
dN λ−=                                                                                                  (5-1)                            
2211
2 NN
dt
dN λλ −=                                                                                           (5-2) 
VR act ⋅Σ⋅= φ                                                                                                     (5-3) 
where, t0 is neutron activation time, φ is neutron flux, Σact is activation cross section, V is 
volume, N1 and N2  are the number of atoms of 142Pr and 142mPr, and λ1 and λ2 are decay 
constant of 142Pr and 142mPr, respectively. 
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Integrating Eq. (5-1) and (5-2) give 
)1()( 1
1
1
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where, A1 and A2  are the activity of 142Pr and 142mPr, respectively. 
 
ii) t > t0 
11
1 N
dt
dN λ−=                                                                                                      (5-8) 
2211
2 NN
dt
dN λλ −=                                                                                           (5-9) 
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The above equations are strictly true if the neutron flux and cross section are 
constant and the number of 141Pr atoms during and after neutron activation is constant. 
As shown Table V-3, the calculation result has excellent agreement with the 
measurement result.
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V-4 Radiochromic film dosimetry 
To verify the Monte Carlo calculation, we measured the two-dimensional dose 
distribution around the seed. The conventional dosimetries such as TLD, polymer gels, 
plastic scintillators, and radiochromic films were surveyed. BANG gel was considered 
for dosimetry measurements, but because of high refractory index of 142Pr REAS glass 
and asymmetric two-dimensional dose distributions of the seed, BANG gel was not used. 
We used radiochromic dye films for measuring the spatial 2-D dose distributions mostly 
because of the very steep gradients around beta sources. Radiochromic film is easy to 
use, dose-rate independent, insensitive to normal room light, self-developing with no 
other processing, and tissue-equivalent. Its color is stable with time after the stabilization 
time of 24 hours. GAFCHROMIC® MD-55-2 (Nuclear Associates) is doubly layered 
and water resistant except for the edge of the films (Butson et al. 2001).    
 
 
Figure V-7. X-ray machine (Norelco MG300) of the Nuclear Science Center 
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The radiochromic films were calibrated using an X-ray machine (Norelco Model 
MG-300) at the Nuclear Science Center shown in Figure V-7. They were cut to about 1 
cm × 3 cm strips and taped onto the holder for exposure. They were carefully managed 
to prevent exposure from direct sunlight because they are sensitive to ultra-violet. The 
radiochromic films were exposed to known doses of X-rays calibrated against a NIST 
traceable ion chamber. The operating parameters of the X-ray machine were 250 kVp 
and 10 mA. After each exposure the color changes of the films were read using an Epson 
Perfection 2480 PHOTO scanner and converted to 8 bit numbers in MATLAB software. 
The MATLAB commands are listed in Appendix III. From the data acquired in Table V-
4, optical densities were generated. The optical density (OD) can be expressed as 
                         

=
I
IOD 0log                                                                            (5-13) 
where I0 is the amount of light transmitted through an unexposed film, and I is the 
amount of light transmitted through irradiated film. 
 
A calibration curve shown in Figure V-8 was derived and fit based on the optical 
density (OD) of the known doses. The calibration curve can be used to measure the dose 
of 2 MeV beta particles without correction. From these data, optical densities were 
generated and 2-dimensional dose profiles were derived.   
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Table V-4. Calibration film image and 8 bit numbers 
0 Gy 2 Gy 
Color Pixel value (0~256) Color 
Pixel value 
(0~256) 
 203  192 
5 Gy 10 Gy 
Color Pixel value (0~256) Color 
Pixel value 
(0~256) 
 179  162 
20 Gy 50 Gy 
Color Pixel value (0~256) Color 
Pixel value 
(0~256) 
 133  90 
70 Gy  
Color Pixel value (0~256) Color 
Pixel value 
(0~256) 
 70   
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Figure V-8. Calibration data and fitted curve of MD-55-2 
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V-5 Experiment procedures 
 
Table V-5. The experiment time sequence 
No. Sequence 
(start time) 
Duration Time 
 
142Pr 
activity 
Comments 
1 Activation 1 h 0:00:00 0 mCi D7TI device 
2 Decay time 30 min 1:00:00 5.53 mCi Decay time (short- 
lived radionuclides) 
3 Handling 30 min 1:30:00 5.94 mCi  
4 Film Irradiation 1 half-life of 142Pr 
(19.12 h) 
2:00:00 5.95 mCi  
5 Film Stabilization 1 day 21:07:12 -  
6 Film Scan - - -  
7 Activity 
Measurement 
4 day after EOI 
(5 half-life, ~1/32)
- 214.50 µCi  
 
First of all, the seed was cut to the precise length and smoothed with sandpaper 
and weighed. After that, the seed was put in a plastic container with a cushion. The 
container was sealed in an aluminum can. The can was placed in special equipment for 
installation at reactor core location D7. The equipment was moved to D7 location with 
full power operation following operation procedure (NSC 2003). After a given time, the 
equipment was removed from the core and stored in the pool for 30 minutes to allow 
decay of short half-life radionuclides such as 28Al. The activated seed was removed and 
placed in an experimental set-up. The seed irradiated the radiochromic film for a given 
time (19.12 h, one half-life of 142Pr). After that, the seed was stored in lead-shielded 
storage to decay. The radiochromic film was stored in light-shielded area for 
stabilization. After 1 day of film stabilization time, the film was scanned. After several 
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half-lives of 142Pr, the activity of seed was measured with a HPGe detector. Table V-5 
presents the time sequence of the experiments. The activities are estimated assuming that 
the experiment is conducted in the exact time sequence. 
 
V-6 Experiment I – Radial dose profile 
Experiment I was conducted to measure radial dose distribution at the axial 
center. Figure V-9 shows a schematic diagram of the source-film arrangement in a solid 
water phantom. The solid water phantom (manufactured by Gammex®) simulated water 
or tissue equivalent medium. The Solid WaterTM phantom material is designed to have 
the same electron density as water. The hole above the glass seed was filled with TLD 
rods. The electron density of TLD chips has a little more than that of tissue or pure water, 
but this effect is negligible. 
Figure V-10 shows the film image and dose contour for 19.12 hour exposure 
with an initial activity of 5.51 mCi. The center of the film was removed during drilling 
so the dose at surface was not measured.  The radial dose profile is axisymmetric as 
expected. Figure V-11 shows the comparisons of radial dose profiles. MCNP calculation 
results agree well with film measurement results from 0.4 cm to 0.65 cm. Beyond 0.65 
cm, MCNP5 underestimates the dose.  
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Figure V-9. Experiment setup for radial dose distribution 
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Figure V-10. (a) transverse-plane isodose plots of radiochromic film, (b) radiochromic 
film image of 142Pr seeds 
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Figure V-11. Radial dose distribution 
 
 
V-7 Experiment II – Axial dose profile 
As shown in Figure V-12, a solid water phantom was used to provide full 
backscattering conditions during measurements. The radiochromic film was placed on 
the top of the solid water phantom. Distilled water inside a thin plastic film (Reynolds®) 
was put in a plastic cup with bottom removed. The thin plastic film prevented the 
distilled water from wetting the radiochromic film. The activated Pr glass seed was 
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placed in the middle of the bottom of a container of distilled water and the radiochromic 
film exposed for known times. 
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Figure V-12. Experiment setup for two-dimensional dose distributions 
 
 
Radiochromic film was exposed one hour post-irradiation for 19.12 hours (one 
half life of 142Pr). Figure V-13 shows the two-dimensional dose profiles from Monte 
Carlo simulation and film measurement. The interpolation was performed using the 
kriging algorithm in the SURFER® program. The calculated and measured dose 
distributions were in excellent agreement. The sensitivity of the radiochromic film is 
from 3 to 100 Gy, so the doses above 200 Gy are not shown for film measurement.  
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Figure V-13. (a) two-dimensional dose profiles of radiochromic film for 19.12 hour 
exposure with 5.95 mCi seed, (b) comparison of isodose plots of Monte Carlo 
calculation (solid lines) and radiochromic film measurement (dotted lines) 
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The total doses at r = 6 mm and θ = 90o and at r = 6 mm and θ = 0o were 
calculated to be 130.8 Gy and 192.7 Gy respectively. Considering that a second seed 
positioned on a 1.2 cm center to center grid would double the dose at this point shown in 
Figure V-14, the dose at r = 6 mm and θ = 90o can be equal to 261.6 Gy. The results 
show that the seed can achieve the target dose and meet the seed design criteria. 
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Figure V-14. Two-dimensional dose profiles using radiochromic film for two seeds (in 
Gy) 
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CHAPTER VI 
AAPM TG-60 DOSIMETRIC PARAMETERS 
 
VI-1 Dosimetry parameters 
The dosimetric parameters defined in AAPM TG-60/TG-43 were determined 
using the Monte Carlo calculations, including: reference dose rate, geometry function, 
radial dose function and anisotropy function. The coordinate system can be seen in 
Figure V-3. The dose at a point can be expressed as 
 
),()()],(/),([),(),( 0000 θθθθθ rFrgrGrGrDrD ⋅⋅⋅=                                        (6-1) 
 
 
where r is radial distance from the source, θ is angle between the line segment from 
point of interest to center of source, G(r,θ) is geometry function resulting from spatial 
distribution of the radioactivity within the source, g(r) is radial dose function, F(r,θ) is 
anisotropy function describing the dose variation and D(r0,θ0) is the dose rate in water at 
the reference point. The reference point suggested in AAPM TG-60 is r0 = 2 mm and θ0 
= 900. Table VI-1 presents the lookup dose rate table.  
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Table VI-1. Lookup dose rate table in rad/h/µCi 
θ, deg 
r, mm 90 80 70 60 50 40 30 20 10 0 
0.10 6.71E+0 6.90E+0 7.22E+0 7.88E+0 9.19E+0 1.15E+1 1.57E+1    
0.15 3.80E+0 3.89E+0 4.17E+0 4.64E+0 5.47E+0 6.89E+0 9.35E+0 1.52E+1   
0.20 2.41E+0 2.46E+0 2.67E+0 3.03E+0 3.66E+0 4.62E+0 6.50E+0 1.05E+1   
0.25 1.59E+0 1.63E+0 1.77E+0 2.05E+0 2.51E+0 3.29E+0 4.76E+0 7.79E+0   
0.30 1.06E+0 1.10E+0 1.21E+0 1.42E+0 1.76E+0 2.41E+0 3.55E+0 6.00E+0 1.45E+1  
0.35 7.11E-1 7.36E-1 8.32E-1 9.80E-1 1.25E+0 1.72E+0 2.59E+0 4.61E+0 1.15E+1  
0.40 4.73E-1 4.95E-1 5.50E-1 6.75E-1 8.82E-1 1.23E+0 1.87E+0 3.27E+0 8.69E+0  
0.45 3.11E-1 3.26E-1 3.70E-1 4.57E-1 6.11E-1 8.48E-1 1.28E+0 2.16E+0 4.65E+0  
0.50 1.94E-1 2.06E-1 2.42E-1 3.10E-1 4.15E-1 5.83E-1 8.63E-1 1.34E+0 2.19E+0 3.84E+0
0.55 1.24E-1 1.26E-1 1.49E-1 2.03E-1 2.76E-1 4.00E-1 5.75E-1 8.24E-1 1.16E+0 1.45E+0
0.60 7.16E-2 7.74E-2 9.54E-2 1.29E-1 1.75E-1 2.65E-1 3.70E-1 5.32E-1 6.65E-1 7.57E-1
0.65 4.18E-2 4.10E-2 5.33E-2 8.04E-2 1.16E-1 1.73E-1 2.46E-1 3.38E-1 4.17E-1 4.42E-1
0.70 2.01E-2 2.25E-2 3.21E-2 4.71E-2 7.35E-2 1.10E-1 1.61E-1 2.14E-1 2.56E-1 2.75E-1
0.75 1.02E-2 1.09E-2 1.68E-2 2.63E-2 4.30E-2 6.59E-2 9.95E-2 1.34E-1 1.63E-1 1.69E-1
0.80 4.39E-3 5.32E-3 9.14E-3 1.35E-2 2.59E-2 4.15E-2 6.36E-2 8.49E-2 1.01E-1 1.06E-1
0.85 2.33E-3 2.40E-3 4.73E-3 7.54E-3 1.40E-2 2.27E-2 3.85E-2 5.25E-2 6.20E-2 6.48E-2
0.90 9.01E-4 1.27E-3 1.59E-3 3.02E-3 6.87E-3 1.20E-2 2.08E-2 3.15E-2 3.91E-2 4.26E-2
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VI-2 The reference dose rate for 142Pr source D(r0,θ0) 
 
The dose rate at reference dose point D(r0,θ0) and a target point D(r=6mm,θ0) 
derived based on two-dimensional dose distributions in water is presented in Table VI-2.  
 
 
Table VI-2. The reference dose rate 
 
Dose point Dose rate (rad/h/µCi) 
r  = 2 mm, θ = 90o 2.412 ± 0.0099 
r  = 6 mm, θ = 90o 0.072 ±0.0017 
 
 
 
VI-3 The geometry function, G(r, θ) 
 
From the definition in TG-43, the geometry function can be expressed as 
 
2
1),( rrG =θ                       for point source approximation                     (6-2)  
θ
θθ
sin
12
Lr
−=                       for line source approximation                        (6-3) 
 
Because the seed has no cladding nor radio-opaque markers and the active length 
is relatively long to get larger coverage, the line source approximation was used. The 
geometry function at the edges of the seed should be higher than that of isotropic source. 
Table VI-3 presents the geometry function times r2 at various angles and distances.  
 
 
72 
 
 
 
Table VI-3. Geometry function, G(r,θ) times r2 
θ, deg 
r, mm 90 80 70 60 50 40 30 20 10 0 
1.00 0.301 0.306 0.323 0.354 0.406 0.493 0.647 - - - 
1.50 0.416 0.424 0.448 0.494 0.570 0.698 0.928 1.409 - - 
2.00 0.512 0.522 0.552 0.610 0.707 0.872 1.172 1.806 - - 
2.50 0.591 0.602 0.638 0.704 0.817 1.011 1.369 2.143 - - 
3.00 0.655 0.667 0.705 0.777 0.900 1.112 1.510 2.392 5.272 - 
3.50 0.708 0.720 0.759 0.833 0.960 1.178 1.588 2.512 5.693 - 
4.00 0.750 0.763 0.802 0.876 1.000 1.212 1.602 2.474 5.549 - 
4.50 0.785 0.797 0.836 0.907 1.025 1.222 1.571 2.296 4.524 - 
5.00 0.814 0.826 0.863 0.930 1.040 1.217 1.514 2.065 3.278 5.263
5.50 0.838 0.849 0.884 0.947 1.047 1.204 1.450 1.853 2.499 3.025
6.00 0.858 0.868 0.901 0.959 1.050 1.187 1.390 1.686 2.062 2.286
6.50 0.875 0.884 0.915 0.968 1.051 1.170 1.338 1.559 1.799 1.920
7.00 0.889 0.898 0.926 0.975 1.050 1.153 1.293 1.463 1.629 1.704
7.50 0.901 0.909 0.935 0.980 1.047 1.139 1.256 1.389 1.510 1.563
8.00 0.911 0.919 0.943 0.984 1.044 1.125 1.224 1.332 1.425 1.463
8.50 0.920 0.927 0.949 0.988 1.042 1.113 1.198 1.287 1.360 1.389
9.00 0.927 0.934 0.955 0.990 1.039 1.102 1.176 1.251 1.311 1.333
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VI-4 The radial dose function, g(r) 
 
The radial dose function, g(r) is calculated as  
 

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The radial dose function can be expressed using a least squares fit of a fifth order 
polynomial as  
5
5
4
4
3
3
2
210)( rararararaarg +++++=                                                         (6-5) 
 
Table VI-4 presents the radial dose function g(r) 5th order polynomial 
coefficients valid from 1.0 mm to 10 mm. The coefficient of determination is 0.999. 
 
 
Table VI-4. 5th order polynomial coefficients 
 
Coefficient Value 
a0 1.2623376 
a1 -0.0187000 
a2 -0.0735998 
a3 0.0087016 
a4 -0.0000594 
a5 -0.0000183 
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VI-5 The 2D anisotropy function, F(r,θ) 
 
The 2D anisotropy function, F(r,θ), is defined as 
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The 2D anisotropy function describes the variation of the dose rate around the 
seed, in the r distance and θ direction. The maximum value of the anisotropy function 
was estimated to 32.863. This is because the isodose profile is elliptical as seen in Figure 
VI-1. Most conventional seeds have a significant cold spots at the ends of the seed due to 
self-attenuation through the seed and encapsulation welds at the edges, while the Pr seed 
has no cold spots near the source ends as shown in Figure VI-1. Table VI-5 presents the 
anisotropy function values.  
 
 
 
 
Figure VI-1. (a) radiochromic film image of 142Pr seeds, (b) autoradiograph of 131Cs 
Seed, available at http://www.isoray.com/assets/InvestorPresentation9606lw.pdf (“seed” 
superimposed and scaled for illustration) 
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Table VI-5. Aniostropy function 
 
θ, deg  
r, mm 90 80 70 60 50 40 30 20 10 0 
1.0 1.000 1.010 1.002 0.997 1.014 1.048 1.083    
1.5 1.000 1.006 1.020 1.030 1.053 1.083 1.106 1.187   
2.0 1.000 1.000 1.025 1.056 1.100 1.124 1.179 1.234   
2.5 1.000 1.002 1.028 1.079 1.138 1.205 1.289 1.349   
3.0 1.000 1.021 1.058 1.125 1.203 1.334 1.449 1.547 1.701  
3.5 1.000 1.017 1.090 1.169 1.298 1.455 1.625 1.823 2.009  
4.0 1.000 1.030 1.088 1.222 1.399 1.610 1.847 2.096 2.485  
4.5 1.000 1.030 1.118 1.273 1.502 1.751 2.057 2.373 2.597  
5.0 1.000 1.047 1.180 1.399 1.677 2.012 2.393 2.732 2.801 3.062
5.5 1.000 1.005 1.139 1.451 1.781 2.250 2.683 3.011 3.149 3.250
6.0 1.000 1.068 1.269 1.609 1.992 2.674 3.192 3.785 3.870 3.969
6.5 1.000 0.971 1.220 1.738 2.313 3.098 3.847 4.541 4.847 4.814
7.0 1.000 1.105 1.533 2.132 3.093 4.212 5.484 6.455 6.947 7.118
7.5 1.000 1.061 1.590 2.373 3.640 5.128 7.021 8.531 9.551 9.594
8.0 1.000 1.202 2.014 2.852 5.155 7.669 10.800 13.231 14.655 15.050
8.5 1.000 1.022 1.971 3.018 5.323 8.064 12.720 16.118 18.026 18.430
9.0 1.000 1.395 1.712 3.142 6.807 11.207 18.183 25.897 30.750 32.863
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CHAPTER VII 
CLINICAL PLANNING 
 
VII-1 Treatment planning 
To treat a patient effectively, treatment planning should be based on the health 
condition of patient, shape and place of the prostate, PSA level, Gleason score, and other 
factors. There are two types of seed implants, permanent seed implants and temporary 
seed insertion. For permanent seed implants, the half-life of the radionuclide is less than 
100 days and beta emitters or low energy photon emitters are often used to reduce the 
dose to other organs. For temporary seed insertion, the seeds will stay for a certain time 
and will be then removed. There is no half-life limitation for temporary seed insertion. 
The ultrasound-guided transperineal template is used for permanent seed implants, while 
the loader is used for to reduce the dose to medical staff during the operation.   
There are two kinds of treatment planning: pre-operational planning, 
intraoperation planning. Images of the prostate should be prepared for treatment 
planning. Since the shape and place of prostate changes daily, real-time planning has 
come to be preferred. The pre-operational planning is required to predict how many 
seeds and what activity would be needed. Precise digital imaging enables real-time 
planning. During the operation, the image of the seeds in the prostate and real-time 
software should be used to save operation time. 
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Post-implant dosimetry should be performed to find the effects of seed 
displacement and migration. Figure VII-1 shows the process flow diagram suggested in 
AAPM TG-64 report. 
 
 
Planning TRUS/CT/MR
Computerized Dosimetric Planning
Dosimetry
data for
Appropriate
Source
Dose
Specification
and
Prescription
Determine Number and Strength of
Seeds
Order and
Receive Seeds
Seed Assay Prepare OR
Worksheet
Load
Seeds
Sterilize
Seeds
Verify Prostate Positioning in OR
vs. Preplan
Implantation (interpret/adjust/re-optimize dosimetric plan,
tally seeds, radiation safety supervision, radiation survey)
Postimplant Simulation/CT/MR
Computerized Dosimetric Analysis,
Dose Reporting  
Figure VII-1. Process flow diagram for a pre-planned prostate seed implant 
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VII-2  High dose rate (HDR) brachytherapy 
As described in Chapter II, the effect of dose rate is remarkable. In the case of 
permanent seed implant, dose rate is mostly determined by the half-life of seed isotope. 
For HDR, the half-life is not a factor to be considered because the seeds should be 
removed after a certain time. HDR has several advantages over LDR. The total dose is 
delivered to tumor cells in a short period such as 2 hours or less. The effects of seed 
migration, prostate distortion, or edema are very small. However, much higher activity is 
required generally. In case of 142Pr glass seeds, a high fluence rate reactor having more 
than 1015 cm-2sec-1 is generally needed to get the desired activity. One-hour neutron 
activation in 1015 cm-2sec-1 can get about 361 mCi of 142Pr. Within an hour, more than 
150 Gy can be delivered at 0.6 cm from seed center with initial activity of 361 mCi. 
  
VII-3  Dose coverage 
Several tens of seeds are used for the treatment of prostate brachytherapy. The 
three-dimensional dose distributions at prostate can be drawn using juxtaposition of dose 
profile of a single seed. We can use a commercial software such as VariSeedTM or CMS 
software to optimize seed position and dose distribution. From the calculation results, 
the dose point can be expected to satisfy the target dose. The dose coverage per seed is 
presented in Table VII-1. 
 
Table VII-1. Dose coverage per seed 
Prescribed dose 90 Gy 150 Gy 
Volume 1.9 cm3 1.65 cm3 
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The three-dimensional dose profile of a seed can be obtained by interpolation of 
the dose rate table presented in Table VI-1. A fortran program code listed in Appendix D 
using Monte Carlo sampling was developed to find the overall three-dimensional dose 
distributions of prostate. The dose coverage can be determined by the program code. 
One million random positions were sampled to assess dose coverage. AAPM TG-64 
recommends the evaluation of dose uniformity and conformity.  
Figure VII-2 shows the isodose distributions of x-y plane and y-z plane based on 
Monte Carlo calculation results with the initial activity of 5.95 mCi. Ideally 40 seeds can 
cover the entire prostate.  
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a) x-y plane (in Gy) 
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Figure VII-2. Two-dimensional isodose curve based on Monte Carlo calculation 
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VII-4  Seed positioning 
To deliver the prescribed dose to the prostate, seed positioning is critical. This 
can be achieved by the proper dose planning and accurate delivery of the seeds. Two of 
the major factors for the proper dose planning are coverage and conformity. Coverage 
can be defined as the percent of volume in the prostate receiving the prescribed dose or 
more. Even if the prescribed dose is delivered to most of the prostate, cold spots can 
leave viable tumor cells. Cold spots can be of two kinds. One is from a seed’s self-
attenuation which is insignificant for 142Pr glass seed. The other is from the seed position 
which can be caused by inadequate planning of seed position, imprecise implantation, by 
seed migration, or, by the change of prostate volume. During planning and implantation, 
all the expected factors that can cause the cold spots should be considered. The ideal is 
to place the seeds to produce a uniform prescribed dose, which may cause closer 
placement of seeds. The pre-operation treatment planning and positioning was 
commonly used in the past, however, the real time planning and image-guided 
positioning is preferred because the imaging technique of the prostate has advanced and 
the shape and size of the prostate can vary day to day.  
Two loading patterns have been used: uniform loading and peripheral loading. 
Uniform loading places the seeds with uniform spacing which gives more dose to the 
center of the prostate, and especially high doses along the urethra. Peripheral loading is 
nonuniform loading so as to spare the urethra. For 142Pr glass seeds, even for uniform 
loading, doses do not peak at the center of the prostate along the urethra.  
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VII-5 VariSeedTM  
A commercial software package, Variseed 7.1, has been used in a one-year 
research version for case study of seed placement. The VariSeed software is a 
brachytherapy treatment planning package for transperineal ultrasound-guided implants 
(VariSeed 2005). The features of the software are as follows: 
z SeedFinderTM automatically locates seeds in a CT data series, dramatically 
reducing the time needed to create post-operation plans 
z Rules-based Dose Optimization logic creates the ideal pre-plan 
z Dynamic interpolation of contour entries for faster planning 
z Image Fusion for targeted therapies or to compare pre- and post- plans 
z Instantly auto-traces solid line contours from ultrasound images 
z Modifies pre-plan dosimetry as seeds are placed using the Implant View 
(link) real time dosimetry module 
z TwisterTM (link) 3D offers volume acquisition without prostate distortion 
z Exports data to all available automatic needle loading systems. 
 
VariSeed software packages allow pre-operative planning, intra-operative 
planning, and post-operative evaluation of prostate cancer treatment courses.  2-D or 3-D 
images of patients’ prostate from CT or ultra-sound video are used for real-time planning 
and the images are processed with needles and seeds in place. The VariSeed software 
adopts the inverse planning algorithm and tries to spare adjacent critical organs such as 
urethra and rectum wall through an optimized planning system. The real-time planning 
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and isodose contours enable modification of the pre-operative planning and to manually 
correct incorrect insertion of a seed in real time. SourceEdit is one of the VariSeed 
software packages to incorporate a seed characteristics. The user-defined source allows 
us to describe the 142Pr glass seed in addition to the existing 125I and 103Pd seeds. I load 
all the dosimetric parameters such as dose-rate constant, source strength, half-life of 
isotope, radial dose function and anisotropy functions as well as seed dimension and 
geometry using SourceEdit.   
The SourceEdit is designed for the AAPM TG-43 parameters. As 142Pr seed is a 
beta source, the dosimetric parameters should be modified to TG-43 to be incorporated 
to the software.  The equation (7-1) is expressed the dose rate in the form of AAPM  TG-
43. 
 
),()()],(/),([),( 00 θθθθ rFrgrGrGSrD K ⋅⋅⋅Λ⋅=                                            (7-1) 
 
 
where SK is the air-kerma strength and Λ is the dose rate constant in water.  
 
Equating TG-60 to TG-43, dose rate is expressed as the air-kerma strength times 
dose rate constant. 
Λ⋅= KSrD ),( 00 θ                                                                                                (7-2) 
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VII-6 Case study  
A case study was performed to assess the feasibility of the 142Pr seed and to 
model the seed using VariSeed. The main work was the description of the seed, 
optimized planning, and comparison of the planning with the conventional seeds. From 
the case study, we may find how many 142Pr seeds can be used, what the coverage of the 
prostate is, and how much dose is delivered to adjacent organs. A prostate was selected 
that had 49 cm3 of prostate volume as shown in Figure VII-3. The image of the prostate 
includes urethral and rectal walls.  
With the dose-optimized placement method, the system finds the best 
arrangement of sources that most closely satisfies the dose constraint rules we specify. 
For this study, 50 seeds were set for the maximum number of sources per needle. The 
implant volume was set to include the prostate and exclude the urethra for seed 
placement. The dose rules required that the prostate volume be above 100.0% of the 
prescribed dose with 10 as a weighting factor, that the rectal surface be below 45.0 Gy 
with 5 as a weighting factor, and that the urethral surface be below 180.0 Gy with 5 as a 
weighting factor which was the half of the maximum dose described in TG-64 report. 
The prescribed dose for 142Pr seed was set to 90 Gy. Figure VII-3 shows the sagittal, 
coronal, and transverse views with two-dimensional isodose distributions in the prostate 
which should be identical on Monte Carlo calculation results shown in Figure VII-2. The 
yellow, blue and green lines delineate the periphery of the prostate, rectum and urethra. 
The pink line shows the isodose curve of 90 Gy.  
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Figure VII-3. Two-dimensional isodose curve at midplane of prostate for a single 142Pr 
glass seed 
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Figure VII-4 shows the ultrasound-based computer image of transverse section of 
midprostate showing planned seed positions. The optimum seed configuration will 
administer a minimal prescribed dose to the periphery of the prostate while sparing 
uninvolved normal structures. The picture enables easy seed loading for quality control.  
  
 
Figure VII-4. Ultrasound-based computer image of transverse section of midprostate 
showing planned seed positions 
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Figure VII-5.  Planned seed positions and resultant isodose coverage with different 
heights 
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Figure VII-5 shows the planned seed positions and resultant isodose coverage 
with different heights after automatic source placement. Figure VII-6 shows the needle 
loading patterns after dose-optimization planning.    
 
 
Figure VII-6.  Needle loading patterns after dose-optimization planning 
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Based on the dose-optimization planning, the best arrangement of seeds, dose 
coverage, and isodose contours were found. A study was conducted for 125I seeds with 
the same prostate and dose-optimization parameters except that the prescribed dose for 
125I was set to 144 Gy. Table VII-2 presents the comparison of the number of seed, dose 
coverage and undesired dose to adjacent organs of 142Pr glass seed and typical 125I seeds.  
 
Table VII-2. Comparisons of dose-optimization of 125I and 142Pr 
 125I (6733) 142Pr 
Number of Seeds 79 50 
Fraction of the prostate volume 
above the prescribed dose  
79.4 % 89.3 % 
Fraction of the rectum surface 
below 45.0 Gy 
56.9 % 100.0 % 
Fraction of the urethra surface 
below 180.0 Gy 
95.6 % 100.0 % 
 
Fifty 142Pr seeds can deliver the prescribed dose to about 90% of the prostate 
volume, while 20% of the prostate volume is less than the prescribed dose for 125I seeds. 
In this comparison, the coverage by 142Pr glass seeds is higher than that of typical 125I 
seeds. The surface area of the rectal wall exposed by 142Pr glass seeds is less than that by 
125I seeds. 142Pr glass seeds can deliver the prescribed dose to larger volume of prostate 
and the undesirable doses to adjacent organs are less.  
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CHAPTER VIII 
SUMMARY AND CONCLUSIONS 
 
A beta-emitting glass seed is proposed for the brachytherapy treatment of 
prostate cancer. While beta sources have been used for vascular brachytherapy, beta 
sources have not been widely used for cancer therapy. Nevertheless beta sources have 
several desirable properties. Beta sources have short range and are easily shielded, 
lowering extraneous dose to the medical staff as well as the patient. They can give a 
lower dose to the adjacent organs than the low energy photons from 125I or 103 Pd. 
Seed design criteria were developed as follows. The seeds should have chemical, 
mechanical, and biological integrity during neutron activation and in vivo. The cost of 
manufacture of these seeds should be relatively inexpensive. The seeds should be visible 
during seed implants and post implant monitoring with or without radiation opaque 
markers. Finally a target dose should be established at about 0.6 cm from seed’s center. 
A 90 Gy dose for 142Pr is selected as the prescribed dose based on the sensitivity analysis 
of dose from 142Pr and the BED comparison. 
Several beta-emitting nuclides were examined for suitability using DPK methods 
for dose calculation and considering neutron cross sections. Yttrium and phosphorus 
have been used for intravascular brachytherapy. 90Y glass microspheres have been used 
for hepatocellular carcinoma. But 90Y has a small thermal neutron absorption cross 
section and 32P produces relatively lower energy beta particles. Rhenium has large 
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neutron cross section but it is not easy to incorporate into glass because of its volatility. 
142Pr was selected as isotope of choice. 142Pr is made by neutron activation of the 100% 
abundant 141Pr, producing both the 19.12 hour ground state and 14.6 min meta-stable 
state. The 142Pr ground state decays emitting 2.162 endpoint energy beta rays 96.3 % of 
the time and has a 3.7% yield of 1.575 MeV gamma rays. Seeds 0.08 cm in diameter and 
0.9 cm long were manufactured for testing. The seeds were activated in the Texas A&M 
research reactor. The activity produced was as predicted considering the meta-stable 
state and epi-thermal neutron flux.  
142Pr REAS glass seeds have several advantages over the conventional seeds. The 
seed is economical; it costs less than 15 dollars per seed including materials and neutron 
activation costs. Due to the short range of beta particles, the dose to adjacent organs can 
be minimized with the optimized implantation positions of the seeds. Because of the 
short half-life of 142Pr, and the associated high dose rate, distortion of the prostate during 
irradiation is less than with 125I, for example, that has a D90 of 204 days. Pr seeds can 
have very high dose rates, if desired, and give doses up to thousands of Gy to tumors 
near seeds. Because of high density and high atomic number of Pr glass, a radio-opaque 
marker is not necessary. Cladding or encapsulation is not required because the seed is 
unreactive in water or tissue. Variable sizes and shapes of glass seeds can be made and 
the seed is not easily broken. The seed is reusable after a high dose rate (HDR) treatment 
by reactivation.  
The MCNP5 Monte Carlo code was used to calculate the quantitative dosimetric 
parameters suggested in AAPM TG-43/60. The Monte Carlo calculation results were 
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compared with those from a dose point kernel code. The dose profiles have a good 
agreement with each other out to 0.6 cm from the seed. The gamma dose is 0.3 Gy at 1.0 
cm with initial activity of 5.95 mCi and therefore contributes insignificantly to adjacent 
organs. The total uncertainty in dose was estimated to be 3.4 % at 2 mm and 3.6 % at 6 
mm.  
A sensitivity analysis was performed to find the optimum size of the detector in 
the MCNP calculations, the impact of the length of the seed, and the effect of “ITS-
style” energy indexing algorithm. A 0.01 cm radius detector was selected as detector size 
considering associated error and computation time. The radial dose profile will be about 
the same at the transverse-plane at any length longer than 4.5 cm length and the axial 
dose profile will be increased proportional to the length increment.  
Measurements were performed to assess the 2-dimensional axial dose 
distributions using Gafchromic radiochromic films. The radiochromic film was 
calibrated using an X-ray machine calibrated against a NIST-traceable ion chamber. A 
calibration curve was derived using a least squares fit of a second-order polynomial. The 
measured dose distribution agreed well with results from the Monte Carlo simulation.  
The dose at 6 mm from the seed center with initial activity of 5.95 mCi was 
130.8 Gy. AAPM TG-43/60 parameters were determined. The reference dose rate for 2 
mm and 6 mm were 0.67 and 0.02 cGy/s/mCi, respectively. The geometry function, 
radial dose function and anisotropy function were generated. Most conventional seeds 
have significant cold spots at the ends of the seed due to self-attenuation through the 
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seed and encapsulation welds at the edges, while Pr seed has no cold spots near the 
source ends. 
The Pr seed is applicable to HDR. HDR has several advantages over LDR. The 
total dose is delivered to tumor cells in a short period such as 1 or 2 hours. The effect of 
seed migration, prostate distortion, or edema is very small. However, much higher 
activity is required. In case of 142Pr glass seeds, a high fluence rate reactor having more 
than 1015 cm-2sec-1 is needed to get the desired activity. One-hour neutron activation in 
1015 cm-2sec-1 can produce 361 mCi of 142Pr. Within an hour, more than 150 Gy can be 
delivered at 0.6 cm from seed center with initial activity of 361 mCi. 
A case study was performed to assess the feasibility of the 142Pr seed and to 
model the seed using the VariSeed software package. The main work was the description 
of the seed, optimized planning, and comparison of the planning with the conventional 
seeds. With the dose-optimized placement method, the system finds the best 
arrangement of sources that most closely satisfies the dose constraint rules. From the 
case study, we found that 142Pr seeds can deliver the prescribed dose to almost all the 
prostate with less dose to adjacent organs than conventional seeds.   
These seeds can be used for prostate brachytherapy, for permanent breast seed 
implants, and for head and neck cancers. If Pr glass is made in the form of microspheres, 
it can be applicable to hepatocellular carcinoma. 
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APPENDIX A 
MATERIAL TEST SHEET 
A.1 Composition 
SPECTRO X-LAB                                                                            Job Number: R and D
Sample Name Method Sample State Date of Evaluation 
GL0793 Gl0793 Preβtablette 12/30/2005 
GL0793_r01 Gl0793 Preβtablette 12/30/2005 
    
Sample Name Al2O3 [%] SiO2 [%] Sum [%] 
GL0793 15.29 ± 0.06 32.66 ± 0.06 47.95 
GL0793_r01 15.22 ± 0.06 32.73 ± 0.06 47.95 
Average 15.25 32.69 47.95 
Standard deviation 0.05245 0.05505 0.00260 
 
 
A.2 Density 
 
Density Measurements – Ultrapycnometer 1000 
GL-0793; 
+212 µm frit 
Sample 
Wt. (g) 
Meas. 1 
(g/cc) 
Meas. 2 
(g/cc) 
Meas. 3 
(g/cc) 
Test #1 21.2276 4.1009 4.0984 4.1009 
Test #2 26.1264 4.0890 4.0905 4.0867 
Test #3 33.9117 4.0791 4.0817 4.0752 
GL-0793; 
+212 µm frit 
Meas. 4 
(g/cc) 
Meas. 5 
(g/cc) 
Average 
 
Std. Dev. 
Test #1 4.0971 4.0946 4.0984 0.0027 
Test #2 4.0867 4.0899 4.0886 0.0018 
Test #3 4.0749 4.0750 4.0772 0.0031 
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APPENDIX B 
MCNP INPUT DECK 
 
 
Beta    particle  at      water 
c       Cell    Cards 
c       Pr      source 
c       Pr-glass4.0g/cm3 
5       1      -4      -1       2  -3   imp:p,e=1 
c       detector0degree 
11       3      -1  -11  imp:p,e=8 
12       3      -1  -12  imp:p,e=8 
13       3      -1  -13  imp:p,e=8 
14       3      -1  -14  imp:p,e=8 
15       3      -1  -15  imp:p,e=8 
16       3      -1  -16  imp:p,e=8 
17       3      -1  -17  imp:p,e=8 
18       3      -1  -18  imp:p,e=8 
19       3      -1  -19  imp:p,e=8 
20       3      -1  -20  imp:p,e=8 
21       3      -1  -21  imp:p,e=8 
22       3      -1  -22  imp:p,e=8 
23       3      -1  -23  imp:p,e=8 
24       3      -1  -24  imp:p,e=8 
25       3      -1  -25  imp:p,e=8 
26       3      -1  -26  imp:p,e=8 
27       3      -1  -27  imp:p,e=8 
28       3      -1  -28  imp:p,e=8 
29       3      -1  -29  imp:p,e=8 
c       detector10degree 
111       3      -1  -111  imp:p,e=8 
112       3      -1  -112  imp:p,e=8 
113       3      -1  -113  imp:p,e=8 
114       3      -1  -114  imp:p,e=8 
115       3      -1  -115  imp:p,e=8 
116       3      -1  -116  imp:p,e=8 
117       3      -1  -117  imp:p,e=8 
118       3      -1  -118  imp:p,e=8 
119       3      -1  -119  imp:p,e=8 
120       3      -1  -120  imp:p,e=8 
121       3      -1  -121  imp:p,e=8 
122       3      -1  -122  imp:p,e=8 
123       3      -1  -123  imp:p,e=8 
124       3      -1  -124  imp:p,e=8 
125       3      -1  -125  imp:p,e=8 
126       3      -1  -126  imp:p,e=8 
127       3      -1  -127  imp:p,e=8 
128       3      -1  -128  imp:p,e=8 
129       3      -1  -129  imp:p,e=8 
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c       detector20degree 
211       3      -1  -211  imp:p,e=8 
212       3      -1  -212  imp:p,e=8 
213       3      -1  -213  imp:p,e=8 
214       3      -1  -214  imp:p,e=8 
215       3      -1  -215  imp:p,e=8 
216       3      -1  -216  imp:p,e=8 
217       3      -1  -217  imp:p,e=8 
218       3      -1  -218  imp:p,e=8 
219       3      -1  -219  imp:p,e=8 
220       3      -1  -220  imp:p,e=8 
221       3      -1  -221  imp:p,e=8 
222       3      -1  -222  imp:p,e=8 
223       3      -1  -223  imp:p,e=8 
224       3      -1  -224  imp:p,e=8 
225       3      -1  -225  imp:p,e=8 
226       3      -1  -226  imp:p,e=8 
227       3      -1  -227  imp:p,e=8 
228       3      -1  -228  imp:p,e=8 
229       3      -1  -229  imp:p,e=8 
c       detector30degree 
311       3      -1  -311  imp:p,e=8 
312       3      -1  -312  imp:p,e=8 
313       3      -1  -313  imp:p,e=8 
314       3      -1  -314  imp:p,e=8 
315       3      -1  -315  imp:p,e=8 
316       3      -1  -316  imp:p,e=8 
317       3      -1  -317  imp:p,e=8 
318       3      -1  -318  imp:p,e=8 
319       3      -1  -319  imp:p,e=8 
320       3      -1  -320  imp:p,e=8 
321       3      -1  -321  imp:p,e=8 
322       3      -1  -322  imp:p,e=8 
323       3      -1  -323  imp:p,e=8 
324       3      -1  -324  imp:p,e=8 
325       3      -1  -325  imp:p,e=8 
326       3      -1  -326  imp:p,e=8 
327       3      -1  -327  imp:p,e=8 
328       3      -1  -328  imp:p,e=8 
329       3      -1  -329  imp:p,e=8 
c       detector40degree 
411       3      -1  -411  imp:p,e=8 
412       3      -1  -412  imp:p,e=8 
413       3      -1  -413  imp:p,e=8 
414       3      -1  -414  imp:p,e=8 
415       3      -1  -415  imp:p,e=8 
416       3      -1  -416  imp:p,e=8 
417       3      -1  -417  imp:p,e=8 
418       3      -1  -418  imp:p,e=8 
419       3      -1  -419  imp:p,e=8 
420       3      -1  -420  imp:p,e=8 
421       3      -1  -421  imp:p,e=8 
422       3      -1  -422  imp:p,e=8 
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423       3      -1  -423  imp:p,e=8 
424       3      -1  -424  imp:p,e=8 
425       3      -1  -425  imp:p,e=8 
426       3      -1  -426  imp:p,e=8 
427       3      -1  -427  imp:p,e=8 
428       3      -1  -428  imp:p,e=8 
429       3      -1  -429  imp:p,e=8 
c       detector50degree 
511       3      -1  -511  imp:p,e=8 
512       3      -1  -512  imp:p,e=8 
513       3      -1  -513  imp:p,e=8 
514       3      -1  -514  imp:p,e=8 
515       3      -1  -515  imp:p,e=8 
516       3      -1  -516  imp:p,e=8 
517       3      -1  -517  imp:p,e=8 
518       3      -1  -518  imp:p,e=8 
519       3      -1  -519  imp:p,e=8 
520       3      -1  -520  imp:p,e=8 
521       3      -1  -521  imp:p,e=8 
522       3      -1  -522  imp:p,e=8 
523       3      -1  -523  imp:p,e=8 
524       3      -1  -524  imp:p,e=8 
525       3      -1  -525  imp:p,e=8 
526       3      -1  -526  imp:p,e=8 
527       3      -1  -527  imp:p,e=8 
528       3      -1  -528  imp:p,e=8 
529       3      -1  -529  imp:p,e=8 
c       detector60degree 
611       3      -1  -611  imp:p,e=8 
612       3      -1  -612  imp:p,e=8 
613       3      -1  -613  imp:p,e=8 
614       3      -1  -614  imp:p,e=8 
615       3      -1  -615  imp:p,e=8 
616       3      -1  -616  imp:p,e=8 
617       3      -1  -617  imp:p,e=8 
618       3      -1  -618  imp:p,e=8 
619       3      -1  -619  imp:p,e=8 
620       3      -1  -620  imp:p,e=8 
621       3      -1  -621  imp:p,e=8 
622       3      -1  -622  imp:p,e=8 
623       3      -1  -623  imp:p,e=8 
624       3      -1  -624  imp:p,e=8 
625       3      -1  -625  imp:p,e=8 
626       3      -1  -626  imp:p,e=8 
627       3      -1  -627  imp:p,e=8 
628       3      -1  -628  imp:p,e=8 
629       3      -1  -629  imp:p,e=8 
c       detector70degree 
c            711       3      -1  -711  imp:p=8 
712       3      -1  -712  imp:p,e=8 
713       3      -1  -713  imp:p,e=8 
714       3      -1  -714  imp:p,e=8 
715       3      -1  -715  imp:p,e=8 
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716       3      -1  -716  imp:p,e=8 
717       3      -1  -717  imp:p,e=8 
718       3      -1  -718  imp:p,e=8 
719       3      -1  -719  imp:p,e=8 
720       3      -1  -720  imp:p,e=8 
721       3      -1  -721  imp:p,e=8 
722       3      -1  -722  imp:p,e=8 
723       3      -1  -723  imp:p,e=8 
724       3      -1  -724  imp:p,e=8 
725       3      -1  -725  imp:p,e=8 
726       3      -1  -726  imp:p,e=8 
727       3      -1  -727  imp:p,e=8 
728       3      -1  -728  imp:p,e=8 
729       3      -1  -729  imp:p,e=8 
c       detector80degree 
c            811       3      -1  -811  imp:p=8 
c            812       3      -1  -812  imp:p=8 
c            813       3      -1  -813  imp:p=8 
c            814       3      -1  -814  imp:p=8 
815       3      -1  -815  imp:p,e=8 
816       3      -1  -816  imp:p,e=8 
817       3      -1  -817  imp:p,e=8 
818       3      -1  -818  imp:p,e=8 
819       3      -1  -819  imp:p,e=8 
820       3      -1  -820  imp:p,e=8 
821       3      -1  -821  imp:p,e=8 
822       3      -1  -822  imp:p,e=8 
823       3      -1  -823  imp:p,e=8 
824       3      -1  -824  imp:p,e=8 
825       3      -1  -825  imp:p,e=8 
826       3      -1  -826  imp:p,e=8 
827       3      -1  -827  imp:p,e=8 
828       3      -1  -828  imp:p,e=8 
829       3      -1  -829  imp:p,e=8 
c       detector90degree 
c            911       3      -1  -911  imp:p=8 
c            912       3      -1  -912  imp:p=8 
c            913       3      -1  -913  imp:p=8 
c            914       3      -1  -914  imp:p=8 
c            915       3      -1  -915  imp:p=8 
c            916       3      -1  -916  imp:p=8 
c            917       3      -1  -917  imp:p=8 
c            918       3      -1  -918  imp:p=8 
919       3      -1  -919  imp:p,e=8 
920       3      -1  -920  imp:p,e=8 
921       3      -1  -921  imp:p,e=8 
922       3      -1  -922  imp:p,e=8 
923       3      -1  -923  imp:p,e=8 
924       3      -1  -924  imp:p,e=8 
925       3      -1  -925  imp:p,e=8 
926       3      -1  -926  imp:p,e=8 
927       3      -1  -927  imp:p,e=8 
928       3      -1  -928  imp:p,e=8 
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929       3      -1  -929  imp:p,e=8 
c 
900       3      -1  -6    #5 
      #011  #012  #013  #014  #015  #016  #017  #018  #019  #020 
      #021  #022  #023  #024  #025  #026  #027  #028  #029 
      #111  #112  #113  #114  #115  #116  #117  #118  #119  #120 
      #121  #122  #123  #124  #125  #126  #127  #128  #129 
      #211  #212  #213  #214  #215  #216  #217  #218  #219  #220 
      #221  #222  #223  #224  #225  #226  #227  #228  #229 
      #311  #312  #313  #314  #315  #316  #317  #318  #319  #320 
      #321  #322  #323  #324  #325  #326  #327  #328  #329 
      #411  #412  #413  #414  #415  #416  #417  #418  #419  #420 
      #421  #422  #423  #424  #425  #426  #427  #428  #429 
      #511  #512  #513  #514  #515  #516  #517  #518  #519  #520 
      #521  #522  #523  #524  #525  #526  #527  #528  #529 
      #611  #612  #613  #614  #615  #616  #617  #618  #619  #620 
      #621  #622  #623  #624  #625  #626  #627  #628  #629 
      #712  #713  #714  #715  #716  #717  #718  #719  #720 
      #721  #722  #723  #724  #725  #726  #727  #728  #729 
      #815  #816  #817  #818  #819  #820 
      #821  #822  #823  #824  #825  #826  #827  #828  #829 
      #919  #920 
      #921  #922  #923  #924  #925  #926  #927  #928  #929 
      imp:p,e=4 
c       void 
999     0       #5 
      #011  #012  #013  #014  #015  #016  #017  #018  #019  #020 
      #021  #022  #023  #024  #025  #026  #027  #028  #029 
      #111  #112  #113  #114  #115  #116  #117  #118  #119  #120 
      #121  #122  #123  #124  #125  #126  #127  #128  #129 
      #211  #212  #213  #214  #215  #216  #217  #218  #219  #220 
      #221  #222  #223  #224  #225  #226  #227  #228  #229 
      #311  #312  #313  #314  #315  #316  #317  #318  #319  #320 
      #321  #322  #323  #324  #325  #326  #327  #328  #329 
      #411  #412  #413  #414  #415  #416  #417  #418  #419  #420 
      #421  #422  #423  #424  #425  #426  #427  #428  #429 
      #511  #512  #513  #514  #515  #516  #517  #518  #519  #520 
      #521  #522  #523  #524  #525  #526  #527  #528  #529 
      #611  #612  #613  #614  #615  #616  #617  #618  #619  #620 
      #621  #622  #623  #624  #625  #626  #627  #628  #629 
      #712  #713  #714  #715  #716  #717  #718  #719  #720 
      #721  #722  #723  #724  #725  #726  #727  #728  #729 
      #815  #816  #817  #818  #819  #820 
      #821  #822  #823  #824  #825  #826  #827  #828  #829 
      #919  #920 
      #921  #922  #923  #924  #925  #926  #927  #928  #929 
      #900 
      imp:p,e=0 
c       end     of      cell    cards 
 
c       surface card 
c       surface of      water 
1   CZ         0.04 
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2   PZ        -0.45 
3   PZ         0.45 
6   SO            2 
c       7CZ         0.02 
c       detector0degree 
11  S          0.1       0       0    0.005 
12  S         0.15       0       0    0.01 
13  S          0.2       0       0    0.01 
14  S         0.25       0       0    0.01 
15  S          0.3       0       0    0.01 
16  S         0.35       0       0    0.01 
17  S          0.4       0       0    0.01 
18  S         0.45       0       0    0.01 
19  S          0.5       0       0    0.01 
20  S         0.55       0       0    0.01 
21  S          0.6       0       0    0.01 
22  S         0.65       0       0    0.01 
23  S          0.7       0       0    0.01 
24  S         0.75       0       0    0.01 
25  S          0.8       0       0    0.01 
26  S         0.85       0       0    0.01 
27  S          0.9       0       0    0.01 
28  S         0.95       0       0    0.01 
29  S            1       0       0    0.01 
c       detector10degree 
111  S     0.098         0    0.017   0.005 
112  S     0.148         0    0.026   0.01 
113  S     0.197         0    0.035   0.01 
114  S     0.246         0    0.043   0.01 
115  S     0.295         0    0.052   0.01 
116  S     0.345         0    0.061   0.01 
117  S     0.394         0    0.069   0.01 
118  S     0.443         0    0.078   0.01 
119  S     0.492         0    0.087   0.01 
120  S     0.542         0    0.096   0.01 
121  S     0.591         0    0.104   0.01 
122  S      0.64         0    0.113   0.01 
123  S     0.689         0    0.122   0.01 
124  S     0.739         0     0.13   0.01 
125  S     0.788         0    0.139   0.01 
126  S     0.837         0    0.148   0.01 
127  S     0.886         0    0.156   0.01 
128  S     0.936         0    0.165   0.01 
129  S     0.985         0    0.174   0.01 
c       detector20degree 
211  S    0.094          0    0.034   0.005 
212  S    0.141          0    0.051   0.01 
213  S    0.188          0    0.068   0.01 
214  S    0.235          0    0.086   0.01 
215  S    0.282          0    0.103   0.01 
216  S    0.329          0     0.12   0.01 
217  S    0.376          0    0.137   0.01 
218  S    0.423          0    0.154   0.01 
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219  S     0.47          0    0.171   0.01 
220  S    0.517          0    0.188   0.01 
221  S    0.564          0    0.205   0.01 
222  S    0.611          0    0.222   0.01 
223  S    0.658          0    0.239   0.01 
224  S    0.705          0    0.257   0.01 
225  S    0.752          0    0.274   0.01 
226  S    0.799          0    0.291   0.01 
227  S    0.846          0    0.308   0.01 
228  S    0.893          0    0.325   0.01 
229  S     0.94          0    0.342   0.01 
c       detector30degree 
311  S   0.087           0     0.05   0.005 
312  S    0.13           0    0.075   0.01 
313  S   0.173           0      0.1   0.01 
314  S   0.217           0    0.125   0.01 
315  S    0.26           0     0.15   0.01 
316  S   0.303           0    0.175   0.01 
317  S   0.346           0      0.2   0.01 
318  S    0.39           0    0.225   0.01 
319  S   0.433           0     0.25   0.01 
320  S   0.476           0    0.275   0.01 
321  S    0.52           0      0.3   0.01 
322  S   0.563           0    0.325   0.01 
323  S   0.606           0     0.35   0.01 
324  S    0.65           0    0.375   0.01 
325  S   0.693           0      0.4   0.01 
326  S   0.736           0    0.425   0.01 
327  S   0.779           0     0.45   0.01 
328  S   0.823           0    0.475   0.01 
329  S   0.866           0      0.5   0.01 
c       detector40degree 
411  S   0.077           0    0.064   0.005 
412  S   0.115           0    0.096   0.01 
413  S   0.153           0    0.129   0.01 
414  S   0.192           0    0.161   0.01 
415  S    0.23           0    0.193   0.01 
416  S   0.268           0    0.225   0.01 
417  S   0.306           0    0.257   0.01 
418  S   0.345           0    0.289   0.01 
419  S   0.383           0    0.321   0.01 
420  S   0.421           0    0.354   0.01 
421  S    0.46           0    0.386   0.01 
422  S   0.498           0    0.418   0.01 
423  S   0.536           0     0.45   0.01 
424  S   0.575           0    0.482   0.01 
425  S   0.613           0    0.514   0.01 
426  S   0.651           0    0.546   0.01 
427  S   0.689           0    0.579   0.01 
428  S   0.728           0    0.611   0.01 
429  S   0.766           0    0.643   0.01 
c       detector50degree 
511  S   0.064           0    0.077   0.005 
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512  S   0.096           0    0.115   0.01 
513  S   0.129           0    0.153   0.01 
514  S   0.161           0    0.192   0.01 
515  S   0.193           0     0.23   0.01 
516  S   0.225           0    0.268   0.01 
517  S   0.257           0    0.306   0.01 
518  S   0.289           0    0.345   0.01 
519  S   0.321           0    0.383   0.01 
520  S   0.354           0    0.421   0.01 
521  S   0.386           0     0.46   0.01 
522  S   0.418           0    0.498   0.01 
523  S    0.45           0    0.536   0.01 
524  S   0.482           0    0.575   0.01 
525  S   0.514           0    0.613   0.01 
526  S   0.546           0    0.651   0.01 
527  S   0.579           0    0.689   0.01 
528  S   0.611           0    0.728   0.01 
529  S   0.643           0    0.766   0.01 
c       detector60degree 
611  S    0.05           0    0.087   0.005 
612  S   0.075           0     0.13   0.01 
613  S     0.1           0    0.173   0.01 
614  S   0.125           0    0.217   0.01 
615  S    0.15           0     0.26   0.01 
616  S   0.175           0    0.303   0.01 
617  S     0.2           0    0.346   0.01 
618  S   0.225           0     0.39   0.01 
619  S    0.25           0    0.433   0.01 
620  S   0.275           0    0.476   0.01 
621  S     0.3           0     0.52   0.01 
622  S   0.325           0    0.563   0.01 
623  S    0.35           0    0.606   0.01 
624  S   0.375           0     0.65   0.01 
625  S     0.4           0    0.693   0.01 
626  S   0.425           0    0.736   0.01 
627  S    0.45           0    0.779   0.01 
628  S   0.475           0    0.823   0.01 
629  S     0.5           0    0.866   0.01 
c       detector70degree 
712  S    0.051          0    0.141   0.01 
713  S    0.068          0    0.188   0.01 
714  S    0.086          0    0.235   0.01 
715  S    0.103          0    0.282   0.01 
716  S     0.12          0    0.329   0.01 
717  S    0.137          0    0.376   0.01 
718  S    0.154          0    0.423   0.01 
719  S    0.171          0     0.47   0.01 
720  S    0.188          0    0.517   0.01 
721  S    0.205          0    0.564   0.01 
722  S    0.222          0    0.611   0.01 
723  S    0.239          0    0.658   0.01 
724  S    0.257          0    0.705   0.01 
725  S    0.274          0    0.752   0.01 
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726  S    0.291          0    0.799   0.01 
727  S    0.308          0    0.846   0.01 
728  S    0.325          0    0.893   0.01 
729  S    0.342          0     0.94   0.01 
c       detector80degree 
815  S    0.052          0    0.295   0.01 
816  S    0.061          0    0.345   0.01 
817  S    0.069          0    0.394   0.01 
818  S    0.078          0    0.443   0.01 
819  S    0.087          0    0.492   0.01 
820  S    0.096          0    0.542   0.01 
821  S    0.104          0    0.591   0.01 
822  S    0.113          0     0.64   0.01 
823  S    0.122          0    0.689   0.01 
824  S     0.13          0    0.739   0.01 
825  S    0.139          0    0.788   0.01 
826  S    0.148          0    0.837   0.01 
827  S    0.156          0    0.886   0.01 
828  S    0.165          0    0.936   0.01 
829  S    0.174          0    0.985   0.01 
c       detector90degree 
c       101  S           0       0    0.05   0.005 
c       102  S           0       0     0.1   0.005 
c       103  S           0       0    0.15   0.005 
c       104  S           0       0     0.2   0.005 
c       105  S           0       0    0.25   0.005 
919  S           0       0     0.5    0.01 
920  S           0       0    0.55    0.01 
921  S           0       0     0.6    0.01 
922  S           0       0    0.65    0.01 
923  S           0       0     0.7    0.01 
924  S           0       0    0.75    0.01 
925  S           0       0     0.8    0.01 
926  S           0       0    0.85    0.01 
927  S           0       0     0.9    0.01 
928  S           0       0    0.95    0.01 
929  S           0       0       1    0.01 
c       end     of      surface cards 
 
MODE    p       e 
c       materialcard 
c       Pr 
c       Si:Al:Pr0.153:0.) 
m1         14000  -0.153   13000  -0.081   59000  -0.445    8000  -0.322 
c       W 
m2         74000       1 
c       water 
c       H       :       2O      :              1 
m3          1001       2    8016       1 
SDEF    cell=5  pos=0  0  0     ERG=d1 PAR=3   rad=d2  ext=d3 axs=0 0 1 
c       SDEF    cell=5  ERG=D1  PAR=3   rad=d2 
SI1  A  0.017 0.172 0.265 0.395 0.574 0.766 0.877 0.946 1.026 1.188  
        1.268 1.343 1.615 1.712 1.884 1.923 2.011 2.064 2.104 2.139 2.160 
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SP1  D  586   656   673   669   649   632   613   598   578   527   
        497   464   311   244   121   95.2  43.4  19.8  7.32  1.19  0.0069 
c  SI1 L 0.017 0.172 0.265 0.395 0.574 0.766 0.946 1.188 1.343 1.712 2.011 2.104 
c  SP1 D 586   656   673   669   649   632   598   527   464   244   43.4  7.32 
SI2            0    0.04 
SP2          -21       1 
SI3        -0.45    0.45 
SP3          -21       0 
c   elpt:e      0.01     0.1  0.1  $cell-bycutoff 
c   phys:e    10       0       0       0       0       1       1       1      10 $bremsstoptions 
*F8:P,E  11   12  13  14  15  16  17  18  19      20 
         21   22  23  24  25  26  27  28  29 
         111 112 113 114 115 116 117 118 119     120 
         121 122 123 124 125 126 127 128 129 
         211 212 213 214 215 216 217 218 219     220 
         221 222 223 224 225 226 227 228 229 
         311 312 313 314 315 316 317 318 319     320 
         321 322 323 324 325 326 327 328 329 
         411 412 413 414 415 416 417 418 419     420 
         421 422 423 424 425 426 427 428 429 
         511 512 513 514 515 516 517 518 519     520 
         521 522 523 524 525 526 527 528 529 
         611 612 613 614 615 616 617 618 619     620 
         621 622 623 624 625 626 627 628 629 
         712 713 714 715 716 717 718 719 720 
         721 722 723 724 725 726 727 728 729 
         815 816 817 818 819 820 
         821 822 823 824 825 826 827 828 829 
         919 920 
         921 922 923 924 925 926 927 928  929 
c       E0 
c       F8:P          10 
NPS     2.00E+09 
DBCN    18J     1  $ITS-styindexing 
PRDMP   1E7 1E8      0       4 
PRINT 
c PRINT   -10   -40   -50   -70   -98   -85   -86    -110    -140    -170    -130    -128 
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APPENDIX C 
MATLAB INPUT DECK 
 
[film,map] = imread(‘file_name.gif’); 
film = map(film); 
[size1, size2] = size(film); 
S_control = 203; 
Odbox = log10(S_control./film); 
A=X; 
B=Y; 
C=Z; 
Odbox2=Odbox*Odbox; 
Gybox=A*Odbox2 + B*Odbox +C; 
C = contour(Gybox)k 
Clabel(C); 
Save test.txt Gybox –ascii; 
C=plot3(Gybox); 
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APPENDIX D 
MONTE CARLO FORTRAN PROGRAM 
 
 
        real pi,re,L,kay,kradius 
        real myu,ke2,myuc,myuph  
! dimension flux(0:27),expo(0:27),fll(20),exl(20) 
  INTEGER(4) iseed 
  open(unit=7,file='cover7-3.out',status='unknown') 
 
!   Global parameters 
 
 
  imax=10000000 
  idose=0 
  iseed=5425001 
 
     pi=3.141592654 
!       radius of prostate 
  kay=2.3         
 
!       length of seed 
        L=0.45 
  doser0t0=30.0 
  referdose=15.0 
   
        do i=1,imax 
 
        dose=0.0 
 
!       step 1-1 : find radius of point 
        call randomtime(iseed) 
     ssai1=RAN(iseed) 
     radius=ssai1**0.333333 
        kradius=kay*radius 
!! write(6,*) 'iseed,ssai1,radius,kradius' 
!! write(6,*) iseed,ssai1,radius,kradius 
 
!       step 1-2 : the angle(phi) of point 
        call randomtime(iseed) 
  ssai2=RAN(iseed) 
  phi=2*pi*ssai2 
!! write(6,*) 'iseed,ssai2,phi' 
!! write(6,*) iseed,ssai2,phi 
 
!       step 1-3 : the angle(theta) of point 
        call randomtime(iseed) 
  ssai3=RAN(iseed) 
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  theta=pi*ssai3 
!! write(6,*) 'iseed,ssai3,theta' 
!! write(6,*) iseed,ssai3,theta 
 
!       step 1-4 : find x,y,z 
        x=kradius*sin(theta)*cos(phi) 
  y=kradius*sin(theta)*sin(phi) 
  z=kradius*cos(theta) 
!! write(6,*) 'x,y,z' 
!! write(6,*) x,y,z 
 
!!   if((z .le. 0.005) .and. (z .ge. -0.005)) then 
!!   write(6,*) '******exceed dose *******,dosert, doser0t0' 
!!   write(6,*) dosert, doser0t0 
!!   write(7,*) 'x,y,z,dosert' 
!!   write(7,*) x,y,z,dosert 
!!   end if 
 
!  if seed is vertical, axis=1.0(z parallel) 
!  if seed is horizontal(y paralle), axis=2.0 
!  if seed is horizontal(x paralle), axis=3.0    
 
!!  ------------------------------------------------ 
        x0=-1.8 
           y0=0.3 
           z0=0.0 
        axis=1.0 
 
!! write(6,*) 'dose1, dosert' 
!! write(6,*) dose, dosert 
 
        if((z .eq. z0) .and. (y .eq. y0) .and.  & 
  (x .eq. x0)) then 
     dose=10000.0 
! idose=idose+1 
         
  else 
               
        call finddose(x,y,z,x0,y0,z0,L,idose, & 
                  dosert,doser0t0,axis,pi,dose,dist) 
 
!! write(6,*) 'dose2, dosert' 
!! write(6,*) dose, dosert 
 
 
        endif 
!! ------------------------------------------------------ 
        x0=-1.2 
      y0=0.3 
      z0=0.0 
        axis=1.0 
        if((z .eq. z0) .and. (y .eq. y0) .and.  & 
  (x .eq. x0)) then 
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     dose=10000.0 
! idose=idose+1 
      
  else 
              
        call finddose(x,y,z,x0,y0,z0,L,idose, & 
                  dosert,doser0t0,axis,pi,dose,dist) 
        endif 
!! -------------------------------------------------------- 
 
    if(dose .gt. referdose) then 
!!   write(6,*) '******exceed dose *******,dosert, doser0t0' 
!!   write(6,*) dosert, doser0t0 
!!   write(7,*) 'x,y,z, dosert' 
!!   write(7,*) x,y,z,dosert 
       idose=idose+1 
    end if 
 
!!   write(6,*) dist 
 
!!   if((dist .le. 0.31) .and. (dist .ge. 0.29) .and. & 
!!   (z .le. 0.1) .and. (z .ge. -0.1)) then 
    if((z .le. 0.01) .and. (z .ge. -0.01)) then 
!!   write(6,*) '******exceed dose *******,dosert, doser0t0' 
!!   write(6,*) dosert, doser0t0 
!!   write(7,*) 'x,y,dose' 
    write(7,*) x,y,dose 
    end if 
 
 
       end do 
 
       ratio=real(idose)/real(imax) 
 
    write(6,*) 'idose, imax, ratio' 
    write(6,*) idose, imax, ratio 
        
     END PROGRAM 
     
 
  
         subroutine randomtime(iseed) 
         USE DFPORT 
         INTEGER(4) iseed 
         character*8 char_time 
!          iseed = TIME( ) 
!          call TIME(char_time) 
         xtime=0.0 
         iseed=iseed+int(1000.0*secnds(xtime)) 
!!     write(6,*) 'secnds(xtime), int(1000.0*secnds(xtime)),iseed' 
!1      write(6,*) secnds(xtime), int(1000.0*secnds(xtime)),iseed 
!         print *, 'Integer: ', int_time, 'time: ', char_time 
         END subroutine 
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        subroutine finddose(x,y,z,x0,y0,z0,L,idose, & 
                   dosert,doser0t0,axis,pi,dose,dist) 
  real L 
 
        if((z .le. z0+L/2) .and. (z .ge. z0-L/2) .and.  & 
  (sqrt((x-x0)**2.0+(y-y0)**2.0) .le. 0.02)) then 
     dosert=10000.0 
! idose=idose+1 
         
  else 
 
        dist=sqrt((x-x0)**2.0+(y-y0)**2.0+(z-z0)**2.0) 
 
        if(axis .eq. 1.0) then 
        angle=acos(abs(z-z0)/dist) 
!! write(6,*) 'seed is vertical, axis, angle,dist' 
!!    write(6,*) angle 
    
  else if(axis .eq. 2.0) then 
        angle=acos(abs(y-y0)/dist) 
 
  else if(axis .eq. 3.0) then 
        angle=acos(abs(x-x0)/dist) 
 
  end if 
 
       if((angle .le. 0.001) .and. (angle .ge. 0.0)) then  
       bgl=1.0/(dist**2.0-L**2.0/4) 
    agl=1.0 
 
    else  
 
 
!         find angle-1, angle-2 
 
          if(axis .eq. 1.0) then 
          dist1=sqrt((x-x0)**2.0+(y-y0)**2.0+(z-(z0-L/2))**2.0) 
          angle1=acos(abs(z-(z0-L/2))/dist1) 
    
          dist2=sqrt((x-x0)**2.0+(y-y0)**2.0+(z-(z0+L/2))**2.0) 
          angle2=acos(abs(z-(z0+L/2))/dist2) 
     
!!    write(6,*) 'seed is vertical' 
!!     write(6,*) 'angle1, angle2' 
!!      write(6,*) angle1,angle2 
 
       
    else if(axis .eq. 2.0) then 
          dist1=sqrt((x-x0)**2.0+(y-(y0-L/2))**2.0+(z-z0)**2.0) 
          angle1=acos(abs(y-(y0-L/2))/dist1) 
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          dist2=sqrt((x-x0)**2.0+(y-(y0+L/2))**2.0+(z-z0)**2.0) 
          angle2=acos(abs(y-(y0+L/2))/dist2) 
     
!!   write(6,*) 'seed is horizontal, y parallel' 
!!         write(6,*) 'angle1, angle2' 
!!      write(6,*) angle1,angle2 
 
    else if(axis .eq. 3.0) then 
          dist1=sqrt((x-(x0-L/2))**2.0+(y-y0)**2.0+(z-z0)**2.0) 
          angle1=acos(abs(x-(x0-L/2))/dist1) 
    
          dist2=sqrt((x-(x0+L/2))**2.0+(y-y0)**2.0+(z-z0)**2.0) 
          angle2=acos(abs(x-(x0+L/2))/dist2) 
     
!!   write(6,*) 'seed is horizontal, x parallel' 
!!         write(6,*) 'angle1, angle2' 
!!      write(6,*) angle1,angle2 
 
    end if 
 
 
       bgl=abs(angle2-angle1)/(L*dist*sin(angle)) 
       agl=abs(angle2-angle1)/(L*dist*sin(pi/2)) 
 
    end if 
 
!!      write(6,*) 'agl,bgl' 
!!   write(6,*) agl,bgl 
 
       dosert=doser0t0*bgl/agl*1106.6*exp(-26.119*dist) 
       dose=dose+dosert 
     
!!   write(6,*) 'dose, dosert' 
!!   write(6,*) dose, dosert 
 
        
    end if 
       return 
    end subroutine 
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